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Cellular therapy holds tremendous potential in regeneration of mineralized tissues such as 
bones and teeth. I have characterized and identified pericytes as a unique population of dental 
pulp stem cells (DPSCs) that can be sorted by CD146+CD34-CD45-CD56-, expanded in culture, 
and differentiated into osteogenic, chondrogenic, and adipogenic lineages. A well-characterized 
stem cell source and an appropriate microenvironment containing growth factors and/or 
extracellular matrix (ECM) proteins to stimulate differentiation and mineralization are required 
for successful cellular therapies. To understand cell-ECM protein interaction, I studied the 
signaling role of phosphophoryn (PP), an ECM protein found in dentin and bone. PP signals 
through integrins, mitogen activated protein kinase (MAPK), and Smad pathways. There is also 
signaling crosstalk between the MAPK and Smad pathways. To better understand the complex 
signaling pathways involved in stem cell differentiation during dentin or bone formation, I have 
utilized quantitative proteomic strategies to study stem cell differentiation triggered by PP and 
BMP-2. Proteins upregulated and downregulated during differentiation were identified by mass 
spectrometry. With the ultimate goal of better enabling the regeneration of diseased or damaged 
mineralized tissue, my findings in this study have enhanced our understanding in stem cell 
differentiation to the osteoblastic/odontoblastic lineages and lay foundations for the development 
of future craniofacial regeneration.  
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1.0  INTRODUCTION 
1.1 TISSUE ENGINEERING FOR CRANIOFACIAL REGENERATION 
Craniofacial reconstruction is necessary to replace or repair damaged or lost tissue in the oral-
facial region. Tissue lost in the oral-facial region can arise for many different situations including 
injury or diseases such as head and neck trauma, cancer, genetic diseases, tooth injury, or 
alveolar bone loss due to periodontal disease. The current technology for treating craniofacial 
defects is to implant an allograft bone substitute seeded with bone marrow aspirate from the ilia 
crest. The grafted defect could be stabilized by titanium screws or bars if the need arises. 
Another approach is to harvest segments of bone from the patient’s ulna or tibia to replace the 
damaged craniofacial tissues; however, this introduces a second injury site that may elicit 
complications and infection.  
Current research in this field is focused on developing tissue engineering strategies to 
regenerate craniofacial defects. To this end, a wide variety of tissues are needed including bone, 
muscle, fat, cartilage, dentin, periodontal ligament, cementum, and dental pulp.  Our specific 
interest is in mineralized tissue engineering which is the regeneration of hard tissues such as 
bone and dentin. 
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1.2 STEM CELL SOURCE FOR CELLULAR THERAPY  
The source of stem cells is an important consideration for cellular therapy. Different types of 
stem cells possess different abilities to differentiate and are suitable for repairing various tissues. 
Stem cells can be categorized into embryonic stem cells, fetal stem cells and adult stem cells. 
The definition of a stem/progenitor cell is that it can self-renew as well as differentiate into at 
least one cell type. For cellular therapy, rejection poses a potential issue; therefore autologous 
stem cells are preferred. Embryonic and fetal stem cells may elicit a body rejection and also raise 
ethical concerns. Cells harvested from tissues that are discarded such as human umbilical vein 
endothelial cells, umbilical cord blood, foreskin, and dental pulp are convenient cell sources for 
cellular therapies. In specific, adult stem cells such as those derived from the bone marrow and 
dental pulp have been shown to be able to differentiation into the bone/dentin lineages and thus 
will be used in our study.[1,2]  
1.2.1 Cellular Therapies 
One approach to repair mineralized tissues is to utilize cellular therapies. Stem cell based 
mineralized tissue engineering requires a well-characterized population of stem cells that can be 
easily sorted, expanded, and induced by growth factors or extracellular matrix proteins (ECM) 
for the desired differentiation. Human bone marrow stromal cells, or mesenchymal stem cells 
(MSC), have been widely studied for differentiation toward osteogenic, chondrogenic, and 
adipogenic lineages.[1] However, mesenchymal stem cells from the craniofacial region have 
been shown to behave differently than those from iliac crest.[2, 3] The differences between the 
MSCs in the craniofacial region and those in the iliac crest might be due to their origin. Most 
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skeletal tissues are derived from the mesoderm except those in the craniofacial region. Neural 
crest cells form much of the mesenchyme of the head and neck, and are derived from the 
ectoderm found at the edges of the neural plate. These cells are also termed neuroectoderm or 
ectomesenchyme.[4] The pulp of adult third molars contains stem cells derived from the 
ectomesenchyme. Because of their unique neural crest origin, dental pulp stem cells may serve as 
a favorable alternative to bone marrow stromal cells for craniofacial tissue regeneration. Dental 
pulp stem cells from the adult third molars, isolated using fluorescent activated cell sorting 
(FACS), can be induced to differentiate by appropriate growth factors and incorporated into 
biocompatible scaffolds which can be useful for bioengineering of craniofacial mineralized 
tissues. In addition, they can provide a model to better understand the biological phenomena 
involved in cell differentiation towards the osteoblastic/odontogenic lineages and bone 
regeneration. Finally, these dental pulp stem cells can also be used to study epithelial-
mesenchymal interactions instrumental to the formation of future bioengineered teeth.   
1.2.2 Pericytes as a Unique Stem Cell Population 
Pericytes, also known as Rouget or mural cells, are microvascular cells surrounding the 
endothelial cells that emerged from the mesodermal origin.[5] Pericytes reside around the walls 
of microvessels (precapillaries, capillaries, and postcapillary venules) and are neither endothelial 
cells nor smooth muscle cells.[6, 7] Pericytes are distributed throughout the vasculature in the 
body with diverse characteristics, function, and location.[8] For example, pericytes in liver, also 
known as Ito cells, serve as a mediator between sinusoids and hepatocytes to facilitate metabolic 
interactions.[9] In general, pericytes interact with endothelial cells to regulate endothelial cell 
proliferation and differentiation.[10] Pericytes are also involved in angiogenesis, maintaining 
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blood flow, as well as providing mechanical strength to the microvessels.[7, 10, 11] It has been 
suggested that pericytes may play a role in the growth, maintenance and repair of the 
skeleton.[12] Pericytes may also be associated with diseases involving ectopic calcification.[13]  
Studies have shown pericytes to be a mesenchymal stem cell (MSC)-like population with 
the capacity to differentiate into multiple mesenchymal lineages: smooth muscle cells, 
osteoblasts, chondrocytes, and adipocytes.[5, 10, 14-16] Bone marrow stromal cells, or MSCs, 
are in fact perivascular cells that are viewed as a special subset of pericytes.[17] Pericytes have 
been isolated from retina, brain, epididymal fat pad, skin, lung, placenta, aorta, and dental pulp 
from various species (human, bovine, rat, monkey).[8, 10, 18, 19] Studies have shown pericytes 
to behave osteoblast-like in vitro even without addition of β-glycerophosphate.[20, 21] Human 
placental pericytes express bone associated proteins, matrix Gla protein and osteopontin 
(OPN).[19, 20] Pericytes from bovine retinal microvessels express alkaline phoshpatase, runx2, 
OPN, osteonectin (ON), osteocalcin (OCN), and bone sialoprotein (BSP) at different stages of 
differentiation.[10, 15] Osteocalcin concentration is higher in the bone cell when compared to 
perictyes.[22] Bovine retina pericytes have also been shown to have osteogenic potential in vivo 
using diffusion chambers.[23]  
However, pericytes used in the studies mentioned above were not sorted, but identified to 
be pericytes by the source of isolation, morphology, and characteristics such as forming nodules 
post confluence. There is no specific marker for pericytes, but there are markers expressed by 
pericytes as well as other cell populations such as 3G5, NG2, CD146, Stro-1, α-SMA, Desmin, 
and ON.[7, 8, 11, 18, 24] Studying pericytes is therefore extremely challenging and there is a 
significant need for a combination of specific markers to sort pericytes exclusively. Dr. Péault’s 
group has characterized and isolated pericytes from human white adipose tissue, fetal and adult 
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muscle, fetal pancreas, and fetal lung using the combination of markers CD146+CD34-CD45-
CD56- and showed multilineage potential of sorted pericytes.[25] In collaboration with Dr. 
Péault we will test this combination of markers for pericytes to isolate human dental pulp tissue.    
1.2.3 Stem Cell Populations in Dental Pulp 
Dental pulp is a highly vascularized tissue and has been proposed to be a stem cell niche.[3, 26] 
Pulp cells, like osteoblasts/odontoblasts, express bone/dentin markers such as bone sialoprotein 
(BSP), alkaline phosphatase, type I collagen, OCN, ON, parathyroid hormone/parathyroid 
hormone related peptide (PTH/PTHrp) receptor, and dentin sialophosphoprotein (DSPP).[26, 27] 
However, the identity of stem cell populations in the dental pulp remain unclear.   
Shi et al. have recently identified mesenchymal stem cells in adult human dental pulp and 
human primary teeth: dental pulp stem cells (DPSC) and stem cells from human exfoliated 
deciduous teeth (SHED). DPSC and SHED were reported to have stem cell like qualities such as 
self-renewal ability and multi-lineage differentiation.[26] Shi et al. observed clonogenic 
populations of DPSCs that were not sorted, but isolated by its ability to adhere to plastic, similar 
to bone marrow stromal cells. DPSCs also share similar gene expression profile with bone 
marrow stromal cells.[28] Non-sorted DPSCs form mineralized nodules in vitro and generate 
dentin-pulp-like tissue in vivo.[29, 30] SHEDs were isolated (but not sorted), expanded, and 
showed 9% Stro-1 positive by FACS. Sections of deciduous incisor pulp were positive for 
CD146 and Stro-1 for cells in perivascular areas. SHEDs are clonogenic and able to differentiate 
into neural cells, adipocytes, and odontoblasts in-vitro as well as osteogenic and odontogenic in 
vivo.[31]  
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The studies mentioned above suggested the stem cells are perivascular cells in the dental 
pulp by a descriptive manner using immuhohistochemistry (IHC) but they were not sorted 
routinely with FACS. There has been little effort in characterization and differentiation of sorted 
dental pulp cells. In only one study, Shi and Gronthos’ group sorted DPSCs by Stro-1, a 
mesenchymal stem cell marker, and then characterized them by IHC to be positive for the 
perivascular markers CD146 and 3G5, but negative for the endothelial and hematopoietic 
markers VWF, CD34, and CD45. They also sorted DPSCs by CD146 and observed ectopic 
dentin formation in immunocompromised mice.[32] Non-sorted pulp cells isolated by Alliot-
Licht’s group formed mineralized nodule and expressed alpha-SMA (a marker for pericytes and 
smooth muscle cells).[33] Tacles et al. showed pulp stem cells in the perivascular area proliferate 
in response to dentin injury.[34] Together, these results led us to our hypothesis that pericytes in 
the dental pulp are in fact a stem cell population, but we needed to develop a strategy to isolate 
the pericytes since Stro-1 and CD146 are also expressed by other cell types. In this study, we 
will characterize the pericytes by immunohistochemistry and determine an optimal combination 
of specific markers to specifically sort dental pulp pericytes by FACS. From our 
immunohistochemistry results, we have characterized pericytes from the dental pulp to be 
positive for CD146 but negative for CD34, CD45, and CD56 similar to pericytes found in other 
tissues. Using these results, we developed a protocol to isolate the pericytes by FACS by first 
excluding CD45+ and CD56+ cells, then selecting for the CD146+CD34- population. This 
provides us with a well-characterized stem cell population with high purity from human dental 
pulp that can be routinely sorted for expansion and differentiation.   
 However, other stem cells populations could exist in the dental pulp. For example, Laino 
et al. showed Stro-1+ckit+CD34+CD45- sorted population to be stem cells from the dental 
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pulp.[35] Further studies comparing various stem cell populations in the dental pulp different are 
warranted.  
1.3 EXTRACELLULAR MATRIX PROTEINS DIRECTS STEM CELL 
DIFFERENTIATION  
Stem cell maintenance and differentiation is directed by signals in the stem cell niche or 
microenvironment. These signals include mechanical stimuli, chemical stimuli, ECM-cell stimuli 
and cell-cell interaction. The ECM provides structure as well as contains growth factors that 
instruct cells to proliferate, migrate or differentiate.  
1.3.1 ECM Proteins Involved in Bone and Dentin Formation 
Many of the processes involved in bone and dentin formation are very similar. Osteoblast and 
odontoblasts secrete a specialized extracellular matrix that will mineralize. The ECM is believed 
to provide the appropriate signals to maintain the osteoblastic and odontoblastic phenotype. The 
ECM contains collagen and non-collagenous proteins, such as Small Integrin-Binding Ligand N-
Linked Glycoproteins (SIBLINGs). SILBLINGs are found in bone and dentin during 
mineralization and play an important role in directing biomineralization and by signaling stem 
cell differentiation. SIBLINGs include OP, BSP, dentin matrix protein-1 (DMP-1), DSPP (also 
called dentin matrix protein-3 or DMP-3), and matrix extracellular phosphoglycoprotein 
(MEPE).[36] Post-translational modifications of SIBLINGs such as phosphorylation, 
glycosylation, and proteolytic processing can affect its structure and function, as a result 
 7 
directing osteogenesis and dentinogenesis.[37] Our interest is to determine the effect of 
phosphophoryn (PP) on cell signaling and stem cell differentiation in comparison to bone 
morphogenetic protein-2 (BMP-2).  
1.3.1.1 PP 
The DSPP gene codes for two proteins: dentin sialoprotein (DSP) and phosphophoryn (PP). PP is 
primarily found in dentin, but also found in bone at much lower levels. Due to its unique and 
exclusive secretion in mineralized tissues, we hypothesized that phosphophoryn would be needed 
for dentin formation, thus making it of significant interest to study if it has a role in stem cell 
differentiation to osteoblasts or odontoblasts. The isolation of the DMP-3 or DSPP mouse 
genomic clone in our laboratory as well as others demonstrated that demonstrated that DSP and 
PP are cleavage products of a single transcript coded by DMP-3.[38],[39] The same organization 
of the gene was also described in the rat species.[40, 41] The intron/exon structure we obtained 
was characterized and the gene contains 5 exons and 4 introns and ~1.5 kb and 6 kb 3' flanking 
regions. A diagram of the λ clone is shown in Figure 1.1. Exons 2, 3 and 4 code for DSP and 
exon 5 codes for PP, comprised primarily of a repetitive motif: (DSS)n. The (DSS)n motif 
confirms the partial degradation studies of phosphophoryns performed earlier.[42] DSPP is 
localized to chromosome 4, linking mutations in the gene to dentinogenesis imperfecta type 
II.[43, 44] Although initially thought to be tooth-specific, Dspp message is also localized in 
mouse calvaria and rat tibia, although at much lower levels.[37]  
PP is the most abundant NCP in dentin ECM, comprising approximately 50% of the 
ECM protein sector.[44] Like other proteins in the bone/dentin microenvironment, PP is highly 
phosphorylated and anionic in character.[45] PP is exceedingly rich in aspartic acid (D) and 
serine (S) residues, and approximately 85-90% of the serine residues are phosphorylated.[46, 47] 
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The majority of the protein sequence consists of (DSS)n repeats as shown in Figure 1-1.[39, 48] 
Odontoblasts secrete PP along the mineralization front.[49-51] PP has been implicated as a 
regulator of mineral crystal formation.[44, 45, 52, 53] Typical of other non-collagenous proteins, 
the physiochemical properties of PP dictate high affinity for Ca2+ which implicates a role in 
nucleation or modulation of HA crystal formation.[54-56] An RGD domain is present at the N-
terminal end of PP[52, 54], suggesting an auxiliary function in ECM-cell communication and 
initiation of intracellular signaling pathways. 
PP also has a signaling role similar to that of growth factors to regulate cell 
differentiation. Our group has shown that PP can act as a signaling molecule and upregulate 
osteogenic genes in human mesenchymal stem cells (hMSCs), mouse fibroblasts (NIH3T3), and 
mouse osteoblasts (MC3T3-E1). PP regulates hMSC differentiation through the integrin/mitogen 
activated protein kinase (MAPK) signaling pathway.[57] We have also shown that PP activates 
the Smad pathway, which is important in osteogenesis and dentinogenesis.[58] Runx2, Osterix, 
alkaline phosphatase, and osteocalcin were upregulated in hMSCs treated with PP.[57] PP has 
also been reported to act as a co-factor that can enhance BMP-2 in bone formation in a rat 
model.[59] Therefore, we feel that PP is a promising candidate for inducing osteogenic and 
odontogenic differentiation of stem cells.    
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Figure 1-1. Genomic organization of the mouse DMP-3 gene. Exons 2,3 and 4 code for DSP and exon 5 
codes for PP. 
1.3.1.2 BMP-2 
BMP-2, belonging to the transforming growth factor-β (TGF-β) super family, stimulates 
osteoblast diffentiation and bone matrix mineralization through activation of the BMP receptor 
and Smad pathways.[60, 61] BMP-2 has been extensively studied and reported to induce 
osteogenesis in stem cells from bone marrow, dental pulp, and adipose tissue.[62-64] BMP-2 is 
expressed by hMSCs during osteogenic differentiation and it stimulates osteogenic transcription 
factors such as Runx2/Cbfa1, ostrix, distal-less homeobox 5 (Dlx5), and msh homeobox 2 
(Msx2).[61, 65]  BMP-2 along with BMP-7 (OP-1) are the two BMPs currently in clinical use 
for bone regeneration that can be reproducibly produced in biotechnology processes using 
recombinant deoxyribonucleic acid technology.[66] BMP-2 has been demonstrated to heal 
critical-sized bone defects in several animal models and the healing process accelerates with a 
calcium phosphate or liposome carrier.[67] Studies are ongoing to incorporate BMP-2 in 3D 
scaffolds such as chitosan film, collagen sponge, and silk fibrin fibers with nanoparticles of 
 10 
hydroxyapatite.[68-70] Understanding the effect of BMP-2 on stem cell differentiation can 
provide valuable information in bone development and tissue engineering.  
1.4 MECHANISMS UNDERLYING STEM CELL DIFFERENTIATION 
Stem cell differentiation is a complex process where the microenvironment plays an important 
role. This microenvironment contains growth factors and ECM proteins that play a major role in 
cell differentiation and signaling through the activation of signal transduction pathways. After 
the binding of growth factors to specific cell surface receptors, a cascade of signaling events 
leads to the recruitment of transcription factors to the cell nucleus, which then initiates specific 
gene expressions. However, how stem cells become osteoblasts/odontoblasts remains unclear. 
(Figure 1-2)  One of the goals of our research is to investigate intracellular signaling pathways to 
better understand the differentiation process of stem cells.  
 
 
 
 
 
 
 
Mineralization
(Bone/Dentin formation)
Stem Cells
Mechanism of 
Stem Cell 
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Osteoblasts  Odontoblasts
?
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Figure 1-2. Mechanisms of stem cell differentiation triggered by ECM proteins remain a black box.  
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Our recent data show that PP interacts with αvβ3 integrin and signals through the mitogen-
activated protein kinase (MAPK) and Smad pathways. PP appears to play an important role 
during cell differentiation towards the osteoblastic lineage. Our goal is to understand the role of 
PP during cell differentiation. Since BMP-2 is a well known factor in the differentiation of cells 
into osteoblasts, we will utilize BMP-2 as a positive control and compare its signaling effects to 
the signaling role played by PP. In addition, PP and BMP-2 both activate the Smad pathway 
which leads us to speculate on how PP activates Smad1. Figure 1-3 illustrates how PP signals 
through αvβ3 integrin, via the MAPK pathway by activating Jnk, Erk, and P38, but it’s activation 
of the Smad pathway does not appear to arise from interaction with the BMP receptor. However, 
we do not know whether PP binds to only integrin αvβ3 or if it also interacts with other cell 
surface receptors. We will investigate other integrins, such as α2β1, which have been shown to be 
expressed in hMSCs and are involved in osteoblastic differentiation.   
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 Figure 1-3. Working model of PP and BMP signaling pathways 
 
We are interested in comparing PP signaling to BMP-2 signaling pathways because PP 
activates Smads similarly to BMP-2. BMP-2 binds to two types of serine/threonine kinase 
receptors, type I and type II receptors. After BMP binds to its receptor, signals get propagated by 
phosphorylation of the receptor and through its downstream molecules, Smad1, 5, and 8. These 
Smad molecules form a complex which then interacts with Smad4 which translocates to the 
nucleus and interacts with transcription factors such as Runx2 to regulate target gene expression. 
Although BMP-2 has been extensively studied, the mechanism that it induces towards osteoblast 
differentiation is still not fully understood. BMP-2 also stimulates tysorine phosphorylation and 
 13 
phosphotidylinosital 3-kinase (PI3K)/Akt pathways which are involved in osteoblast 
differentiation. It is well known that there is cross-talk between Smads and PI3K/Akt. PI3K, a 
lipid kinase, is often activated by tyrosine phosphorylation induced by binding of specific growth 
factors. PI3K functions as a control point in the signaling cascade.[71] Crosstalk also exists 
between the MAPK and Smad pathways under BMP-2 signaling.[72-74] Erk activation has been 
shown to inhibit Smad[75] while inhibition of P38 was shown to decrease Smad signaling.[76] 
Since we know that PP signals through the MAPK and Smad pathways similarly to BMP-2, we 
have investigated phosphorylated proteins present during differentiation to identify key players 
involved in this process after cells have been treated with recombinant PP (rPP) and recombinant 
human BMP-2 (rhBMP-2). 
1.4.1 Proteomic Approaches to Understanding Stem Cell Differentiation and Signaling 
Pathways 
Signal transduction underlying stem cell differentiation is extremely complex. While one 
approach to study these complex phenomena is to assess one signaling pathway, one molecule at 
a time, this is a lengthy and time consuming process. Novel proteomic strategies utilizing mass 
spectrometry (MS) can provide a systematic and efficient way to provide insight in signaling 
molecules or key players involved in stem cell differentiation. The proteome of mesenchymal 
stem cells has been studied using MS-based methods to understand changes in signaling 
molecules during differentiation.[77] Global proteomic analyses of osteoblast differentiation 
from hMSCs has been studied using 2D-polyacrylamide gel electrophoresis (PAGE)-MS.[78] 
Aside from the identification of signaling proteins involved in differentiation, utilizing 
quantitative methodologies in combination with mass spectrometry will provide the ability to 
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determine proteins that are up- or downregulated in response to treating stem cells with specific 
stimuli.  
1.4.1.1 Quantitative Proteomics 
A variety of MS-based quantification techniques exist to determine relative protein abundance 
changes in samples include metabolic labeling such as stable isotope labeling of cells in culture 
(SILAC), chemical labeling such as isobaric tag for relative and absolute quantitation (iTRAQ) 
or isotope coded affinity tags (ICAT), and difference in-gel electrophoresis (DIGE).[79, 80] 
Studies utilizing these techniques can differentially compare proteomes on a global scale from 
which specific information regarding signaling networks and pathways may be revealed in order 
to determine divergent signaling mechanisms from different treatment conditions. In a recent 
study using the iTRAQ technology, embryonic stem cell differentiation during noggin induced 
neural and BMP-4 induced epidermal ectoderm was investigated.[81] A recent SILAC study 
discovered how epidermal growth factor (EGF) could stimulate mesenchymal stem cell 
differentiation into osteoblasts but not platelet derived growth factor (PDGF). Although more 
than 90% of the signaling proteins were used by both ligands, it was found that the PI3K 
pathway was activated by PDGF but not EGF resulting in a much different effect on the 
cells.[82] Quantitative proteomics has also been used to profile the differential expression of 
membrane proteins of a hMSC cell line during osteoblast differentiation.[83] We used a SILAC-
based global proteomics approach to further investigate the signaling pathways involved in stem 
cell differentiation into the osteogenic and odontogenic lineages stimulated by BMP-2 and PP 
respectively.  
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1.4.1.2 Phosphoproteomics 
Protein phosphorylation is one of the most relevant and ubiquitous posttranslational 
modifications and it plays significant roles in cellular processes. Signals received from outside of 
the cells travels through a cascade of phosphorylation events of multiple proteins into the 
nucleus. An evaluation of the phosphoproteome presents an opportunity to identify and quantify 
these signaling proteins to better understand the cascade of events and processes leading to 
cellular transformation. Phosphorylation occurs mostly on amino acids serine, threonine and 
tyrosine[84] with an approximate ratio of the phosphorylation of those residues in the order of 
1800:200:1.[85] Globaly, phosphorylated proteins in the cell exist at diminishingly low 
abundances of 1-2%.[86] In order to address this analytical hurdle, several methods have been 
developed for enriching phosphopeptides from these complex mixtures including 
immunoprecipitation using phosphospecific antibody such as anti-phosphotyrsosine, 
immobilized metal affinity chromatography (IMAC) with Fe3+, Ga3+, or Al3+, and titanium 
dioxide (TiO2).[87] Each of these techniques have been shown to have different 
phosphoenrichment efficiencies[88, 89] and therefore each technique must be specifically suited 
to the experimental design in question. With the recent successes that have been demonstrated 
using the TiO2–based methodologies, we have utilized that workflow to evaluate the signaling 
events involved in differentiation following treatment with PP or BMP-2 .[90, 91]  
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1.5 HYPOTHESES 
Hypothesis 1: Pericytes are a stem cell population residing in the dental pulp. 
Hypothesis 2: PP plays a signaling role in stem cell differentiation toward the 
osteoblastic/odontoblastic lineage. 
Hypothesis 3: SILAC-based MS will efficiently quantify proteins identified from C3H10T1/2 
cells treated with PP and BMP-2.  
In order to support these hypotheses, the following specific aims have been developed 
1.6 SPECIFIC AIMS & RATIONALE 
1.6.1 Specific Aim 1: Characterization, identification, and isolation of dental pulp stem 
cells (pericytes) 
I will characterize and identify pericytes from human dental pulp by IHC using different 
combinations of marker antibodies, flow cytometery techniques that relies on a combination of 
surface markers CD146+CD34-CD45-CD56-. In addition, I will characterize that the sorted 
pericytes are clonogenic and have multilineage differentiation potential.  
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1.6.2 Specific Aim 2: Identification of cell surface receptors and signaling crosstalk in PP 
signaling in hMSCs.   
I will identify integrin receptor involvement in PP signaling and assess the crosstalk between the 
MAPK and Smad1 pathways. 
1.6.3 Specific Aim 3: Proteomic profiling of mouse embryonic fibroblasts (C3H10T1/2) 
during differentiation into osteoblasts and odontoblasts.   
I will use SILAC to quantify the proteins identified from C3H10T1/2 cells treated with PP and 
BMP-2.  
1.6.4 Rationale of Different Cell Types Selected for Each Aim 
The rationale of using different cell types in each of the specific aims is as the following. 
In specific aim 1, dental pulp pericytes were studied due to the interest in isolating a novel stem 
cell population. Although it would be interesting to test their response to PP, the cell numbers 
obtained were insufficient for those required for specific aim 2. In addition, studies of PP 
signaling were based on previous work in our lab which was done in hMSCs. Therefore, we 
chose to use hMSCs for the second aim of this thesis. For specific aim 3, our original thoughts 
were to use dental pulp pericytes or hMSCs for studying the effect of PP and BMP-2 on 
odontogenic/osteogenic differentiation. However, in order to achieve successful labeling of 
heavy amino acids in cell culture, cells were required to be cultured for at least five doubling 
times. Also, a large quantity of cells is required for mass spectrometry of the phosphoproteome. 
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In this case, dental pulp pericytes would not be suitable due to the limited number of cells 
obtained from FACS. hMSCs are also not suitable because cells might differentiate or stop 
proliferation after multiple passages during heavy amino acid labeling. Therefore, mouse 
embryonic fibroblasts C3H10T1/2 cells, which have multlilineage differentiation potiential and 
can be expanded extensively in culture, were selected for the SILAC experiments. 
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2.0  MULTILINEAGE POTENTIAL OF PRICYTES SORTED FROM HUMAN 
DENTAL PULP 
2.1 SUMMARY 
We document the existence of a perivascular stem cell population in the human dental pulp. 
Pericytes in human dental pulp were characterized by immunohistochemistry as expressing 
CD146, α-smooth muscle actin (α –SMA), NG2, but negative for CD34, von Willebrand factor 
(vWF), CD45 and CD56 expression. This phenotypic description provided the basis for the 
purification by flow cytometry of perivascular CD146+CD34-CD45-CD56- cells from the dental 
pulp.  Long-term cultured dental pulp perivascular cells are clonogenic colony forming units-
fibroblast, express the mesenchymal stem cell markers CD44, CD166 and CD90, and give rise to 
osteoblasts, chondrocytes and adipocytes in vitro. These results suggest that mesenchymal stem 
cells previously isolated from the dental pulp have a perivascular origin. Pericytes sorted to 
homogeneity from extracted dental pulp, then multiplied in culture may represent a convenient 
source of therapeutic progenitor cells.   
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2.2 INTRODUCTION 
The development of effective therapies for craniofacial regeneration is a clinically important 
long-term goal in the tissue engineering field. Craniofacial diseases and disorders ranging from 
periodontal disease and its associated bone loss to birth defects such as cleft lip and palate, to 
craniosynostosis, to injuries to the head and face, to devastating head and neck cancers require 
extensive surgery and would obviously benefit from innovative regenerative cell therapies.  
Dental pulp stem cells (DPSCs) were first described by Gronthos et al., who showed the 
capabilities of these cells to become osteoblastic in vitro and form dentin-like structures in vivo 
.[32] Characterization and isolation of the DPSCs will provide an understanding of the potential 
of these cells in craniofacial regeneration and dentin repair in the event of an injury. DPSCs are 
believed to be pericyte-like cells that migrate towards the pulpal injury site.[34, 92]  Pericytes, 
also known as Rouget cells or mural cells, reside around the endothelium of microvessels 
(capillaries and postcapillary venules), hence are distributed throughout the vasculature with 
diverse roles in the regulation of blood flow and vessel formation.[8] For a long time, pericytes 
under study were not sorted, but identified in primary cultures by morphology, slow adhesion to 
plastic and expression of pericyte-associated (but not pericyte-specific) antigens such as 3G5, 
NG2, CD146, Stro-1, α-SMA, desmin and osteonectin.[7, 8, 11, 18, 24, 93]   
Two groups including our own have recently shown that perivascular cells can be 
purified from multiple human organs including placenta, pancreas, fat and muscle and showed 
the multilineage developmental potential of these cells, suggesting the perivascular origin of the 
elusive mesenchymal stem cells (MSC).[93-98] Pericytes are therefore of potential interest for 
regenerative medicine. While pericytes are ubiquitous in the body, harvesting these cells for 
autologous transplantation should be easy but from a richly vascularized organ, of no risk for the 
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patient and minimally invasive, hence the interest of human tissues that are shed naturally, such 
as fetal appendages and teeth. Teeth, which are lost in the course of normal development 
(primary teeth), and commonly extracted in young adults in the case of wisdom teeth, can be 
envisioned as a source of such autologous stem cells, especially since dental pulp is rich in blood 
vessels.  In the present study, we have identified and purified perivascular cells present in human 
dental pulp. Our approach has relied first on immunohistochemistry (IHC) experiments to 
determine the presence of cell surface markers that could be utilized to sort dental pulp pericytes. 
We then confirmed that sorted dental pericytes could be expanded in culture and are multilineage 
mesodermal progenitors.  
2.3 MATERIALS AND METHODS 
2.3.1 Antibodies 
Unconjugated antibodies used were mouse anti-human CD146, -CD34, -NG2, -CD56, -CD44, -
CD90 (BD Biosciences), -CD45 (DAKO), rabbit anti-human CBFA-1/Runx-2, -osteocalcin, -
PDGFR-β (Santa Cruz Biotechnology). Conjugated antibodies included mouse anti-human 
CD146-Alexa488 (Chemicon), -CD146-FITC (AbSerotec), -CD45-PE-Cy5, -CD56-PE-Cy7 (BD 
Biosciences), -α-SMA-FITC (Sigma), -CD34-PE (DAKO), -CD166-biotin (Ancell), sheep anti-
human vWF-FITC (US Biological), rabbit anti-human CD144-biotin (BMedSystems), donkey 
anti-rabbit-Alexa488, donkey anti-rabbit- Alexa594 (Molecular Probes), goat anti-mouseIgG 
biotin (DAKO), goat anti-mouse-IgM biotin (μ) (Caltag Laboratories), mouse IgG-PE, mouse 
 22 
IgG-FITC (Chemicon), mouse IgG-PE-Cy7, mouse IgG-PE-Cy5 (BD Biosciences) and sheep 
IgG-FITC (US Biological).   
2.3.2 Tooth Procurement and Cell Isolation 
We obtained 85 adult third molars (age 14-23 years) at the School of Dental Medicine, 
University of Pittsburgh, as approved by the Institutional Review Board (IRB number: 0312073).  
Dental pulp was digested with collagenases I, II, and IV (each at 1 mg/mL, Sigma) at 37 ˚C for 2 
h under gentle agitation. Cell suspensions were passed through a 70 μm cell strainer (BD Falcon) 
to obtain single-cell suspensions.  
2.3.3 Immunohistochemistry 
Dental pulps were frozen in Tissue Freezing Medium (Triangle Biomedical Sciences) and 
cryosectioned at 5-µm thickness. Tissue sections were fixed in ice cold 50% methanol and 50% 
ethanol for 5 min, air dried for 15 min and then incubated with 5% goat serum (Gibco) in PBS 
for 1 h at room temperature (RT) to prevent antibody non-specific binding. Tissue sections were 
incubated with primary antibody (1:100 dilution, same dilution for all primary antibodies) 
overnight at 4 ˚C. Appropriate secondary antibodies were used (1:1000 dilution) for 1 h followed 
by streptavidin coupled to Cy3 (1:1000 dilution, Amersham) for 30 min at RT. When two 
antibodies were used simultaneously, the sections were incubated for 1 h at RT with a second 
primary antibody that was already conjugated with either Alexa-488 or FITC. The sections were 
then stained with 4',6-diamidino-2-phenylindole (DAPI, 1:2000 dilution, Molecular Probes) for 5 
min at RT to visualize nuclei. Coverslips were mounted with Gel/Mount mounting medium 
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containing anti-fading agents (Biomeda Corp.). Fluorescent images were acquired by optical and 
confocal microscopy using Nikon Eclipse TE2000-U and Olympus FLUOVIEW FV1000 
microscopes, respectively.  
2.3.4 FACS and Cell Culture 
Freshly digested dental pulp cells were washed with phosphate buffered saline (PBS, Gibco) and 
stained with CD146-FITC, CD34-PE, CD45-PECy5 and CD56-PE-Cy7 antibodies for 30 min at 
4 ˚C (1:100 dilution). Cells were then washed with PBS and resuspended in 1ml of Endothelial 
Cell Growth Medium 2 (EGM-2, Cambrex Bioscience Inc.). A FACSAria dual-laser 
fluorescence activated cell sorter (Becton-Dickinson) was used to isolate CD146+CD34-CD45-
CD56- cells as previously described.[98] 
 Sorted cells were cultured at 37 ˚C, 5% CO2 in EGM-2 on 48-well tissue culture plates 
coated with 2% gelatin (Calbiochem) at 10,000 cells per cm2. After cells attached to the culture 
plate, medium was changed to high-glucose DMEM high glucose (GIBCO) with 20% fetal 
bovine serum (FBS, Atlantic Biological) and 1% penicillin-streptomycin (GIBCO).  
2.3.5 Colony Forming Units-fibroblast (CFU-f) Assay  
Cultured dental pulp perivascular cells were seeded at a density of 100 cells/10cm2 and cultured 
for two weeks to test their clonogenic ability. Cells were fixed with 100% methanol for 5 min, 
air dried for 5 min and stained with 3% Crystal violet (Sigma) for 5 min at RT. Cells were 
washed with distilled water and colonies (>2.5 mm or 50 cells) were counted. Percentage of CFU 
was calculated as the number of colonies counted divided by the number of cells plated, then 
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multiplied by 100. Pericytes isolated from dental pulp of three patients were analyzed. Six plates 
of colonies were counted and scored for each donor. 
2.3.6 Immunocytochemistry 
Sorted dental pulp cells were seeded in 48-well tissue culture plates. Cells were fixed in 1% 
paraformaldehyde (PFA) in PBS or a mixture of ice-cold acetone and methanol (1:1).  Cells were 
washed with PBS, blocked with 5% goat serum, and then incubated with primary and secondary 
antibodies. To detect Runx-2 expression, cells were permeabilized with 0.1% Triton X-100 
(Sigma) during blocking and incubation with antibodies. 
2.3.7 Osteogenic Differentiation 
Dental pulp perivascular cells were seeded at 25,000 cells/cm2 in 6-well tissue culture plates and 
cultured in control medium (high-glucose DMEM with 20% FBS, 1% PS) or osteogenic medium 
for two weeks. Osteogenic medium is control medium supplemented with 50 µg/mL L-ascorbic 
acid (Fisher Biotech), 100 mM ß-glycerolphosphate (Sigma), and 100 nM dexamethasone 
(Sigma). Medium was changed every 3 days. Cells were then fixed and subjected to alkaline 
phosphatase and von Kossa stainings.  
Cells were washed with PBS and fixed with 4% PFA for 15 min at 4 ˚C. For alkaline 
phosphatase staining, cells were incubated with a solution containing 5 mg naphtol AS MX-PO4 
(Fisher Scientific) dissolved in 0.2 mL N,N-dimethylformamide, 25 mL Tris-HCl (0.2 M, pH 8.3, 
Sigma), Red Violet LB salt (30 mg, Sigma), and 25 mL distilled water for 45 min at RT. Cells 
were washed three times with distilled water, then incubated with 5% silver nitrate (Sigma) at 
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RT for 30 min and then rinsed with distilled water three times. Cells were examined and imaged 
by bright field microscopy. Alkaline phosphatase activity was measured quantitatively using the 
Alkaline Phosphatase Kit (Sigma) following manufacturer’s instructions.  Briefly, cell lysates 
were incubated with alkaline phosphatase reagents at 37 °C for 30 min. Absorbance at 405 nm 
was measured at times 0 and 30 min. Alkaline phosphatase activity was normalized to the total 
protein content measured by the BCA protein assay kit (Pierce). All measurements were done in 
triplicate.  
2.3.8 Chondrogenic Differentiation 
Dental pulp perivascular cells were centrifuged for 5 min at 600 x g into 3-dimensional pellets 
(250,000 cells/pellet) and cultured for 14 days in chondrogenic medium that contains high 
glucose DMEM, 10 ng/mL TGF-β1 (Peprotech), 10 µl/mL ITS-plus premix (BD Biosciences 
Clonetech, final concentrations: 6.25 µg/mL each of insulin, transferrin, and selenous acid, and 
1.25 mg/mL bovine serum albumin, and 5.35 µg/mL linoleic acid), 100 nM dexamethasone 
(Sigma), 50 µg/mL ascorbic 2-phosphate (Sigma). Control medium was high-glucose DMEM 
containing ITS-plus premix. Medium was changed every three days.  Each experiment was 
performed in triplicates. Cell pellets were fixed in 4% paraformaldehyde, dehydrated in 
ethanol/xylene series, and paraffin-embedded. Five-µm paraffin sections were stained with 1-
Alcian blue (Sigma) with nuclear fast red (Sigma) counterstain or 2-Safranin O (Sigma) with fast 
green (Sigma) counterstain.   
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2.3.9 Adipogenic Differentiation 
Dental pulp perivascular cells were seeded at 25,000 cells/cm2 in 6-well tissue culture plates and 
cultured in control medium (high-glucose DMEM with 20% FBS, 1% PS) or adipogenic medium 
for two weeks. Adipogenic medium is control medium supplemented with 0.5 mM of 1-methyl-
3-isobutylxanthine (Sigma), 1 µM dexamethasone (Sigma), 0.01 mg/mL insulin (Cell Sciences), 
and 0.2 mM indomethacin (Sigma). Medium was changed every three days for 21 days. Each 
experiment was done in triplicate. Cells were fixed and stained with oil red-O (Sigma).  
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2.4 RESULTS 
2.4.1 Identification of Perivascular Cells on Dental Pulp Sections 
IHC was performed to identify the various cells that constitute vascular areas in human dental 
pulp using the cell surface markers listed in Table 2-1.  
 
Table 2-1. Markers used for IHC 
 
Pericytes CD146, NG2, α-SMA, PDGFR-β 
Endothelial cells CD146, CD34, vWF 
Hematopoietic cells CD34, CD45 
Myoblasts, NK cells CD56 
 
 
 
 
Perivascular cells that surround endothelial cells in capillaries and microvessels are 
anatomically defined as Pericytes.[7, 99, 100] Frozen sections of dental pulp were stained with 
antibodies against pericytes, endothelial cells, neural cells, and hematopoietic cells. Pericytes are 
pointed with arrows. Figure 2-1 A, B, G shows that pericytes in the dental pulp coexpress 
CD146, α-SMA and NG2. Pericytes are negative for CD34, vWF and CD45 expression (Figure 
2-1 C, D, E, and H). Some cells are positive for both CD146 and CD56 expression (Figure 2-1 
F). We deduced that the CD146+NG2+CD34-CD45-CD56- cell surface phenotype typifies all 
pericytes within human dental pulp, as it does in other tissues analyzed so far.[98] 
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Figure 2-1. Immunodetection of pericytes in human dental pulp. A, B - CD146 in red) α-SMA (green) C, D - 
CD146 (green), CD34 (red). Pericytes (P). Endothelial cells (EC). E - CD146 (red), vWF (green). F - CD146 
(green), CD56 (red). G - CD146 (green) NG2 (red) H - CD146 (green) CD45 (red). Nuclei were stained blue with 
DAPI. A, B, D: bar = 50 µm. 
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2.4.2 FACS of Human Dental Pulp Perivascular Cells 
To isolate pericytes by flow cytometry from the enzymatically dissociated dental pulp, we first 
excluded CD45+ hematopoietic cells and CD56+ myogenic and NK cells (Figures 2-2 A, B). 
The dental pulp cell suspension could then be fractionated into three distinct cell populations as 
shown in Figure 2-2 C and outlined below:  
• Endothelial cells: CD34+CD146-CD45-CD56- and CD34+CD146+CD45-CD56-  
• Pericytes : CD146+CD34-CD45-CD56- 
• Uncharacterized CD34-CD146-CD45-CD56- cells 
CD146+CD34-CD45-CD56- pericytes were isolated. Pericytes represent 0.62 ± 0.41%, 
whereas endothelial cells account for 3.43 ± 2.16% of the total dental pulp cell population.  
2.4.3 Clonogenic Capacity and Phenotype of Cultured Dental Pulp Pericytes 
Sorted dental pulp perivascular cells were seeded in culture in EGM-2 medium on gelatin-coated 
plates.  Cell viability was low when less than 1,000 cells were seeded after sorting. Cell viability 
increased when more cells were initially seeded. Cells attached to the bottom of the wells in 
approximately 48-72 h. One week after culture initiation, EGM-2 medium was replaced by 
DMEM supplemented with 20% FBS.  Recently attached cells exhibited mixed elongated, 
spindle and polygonal shapes. After cells were passaged once, they exhibited star-like shapes 
with prominent nuclei and multiple cytoplasmic extensions (Figure 2-2 D, Bar = 100 µm). 
The clonogenic capacity of cultured pericytes was determined by using the CFU-f assay. 
Cells were seeded at a low density of 100 cells/10cm2 and colonies were observed on day 14 by 
crystal violet staining. In vitro cultured dental pulp pericytes are highly clonogenic, 98 ± 2% of 
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these being CFU-f (Figure 2-2 E). Cultured pericytes at passage eight, i.e. cultured for two 
months, maintained expression of the pericyte markers CD146, NG2 and α-SMA (Figure 2-2 F-
H) and remained negative for vWF, CD144, CD45 and CD56 expression (not shown). All 
cultured pericytes were also positive for PDGFR-ß (Figure 2-2 I). These results show that sorted 
pericytes were not contaminated by other cell types and did not change their antigenic 
characteristics when proliferating in culture. To further characterize cultured dental pulp 
pericytes, we tested their expression of several mesenchymal stem cell markers. Cultured 
pericytes express the MSC markers CD44, CD90 and CD166 (Figure 2-2 J, K, L). Pericytes in 
culture express in addition both Runx-2 and osteocalcin, suggesting their inherent osteogenic 
capability (Figure 2-2 M, N).  
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Figure 2-2.  FACS, morphology, CFU-f analysis, and immunocytochemistry of cultured dental pulp pericytes. A, B 
– exclusion of CD56+ and CD45+ cells. C - Selection of CD146+CD34- population. D - Pericytes morphology.  E - 
CFU-f analysis.  F – CD146 (red), G – NG-2 (red), H – α SMA (green), I – PDGFR-β (red),  J – CD44 (red), K – 
CD90 (red), L - CD166 (red),  M – Runx2 (green), N – Osteocalcin (green). Nuclei were stained blue with DAPI. D: 
Bar = 100 µm. F-N: 20x magnification. 
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2.4.4 In vitro Multilineage Differentiation of Cultured Dental Pulp Pericytes 
Cultured pericytes were successfully differentiated into osteocytes, chondrocytes and adipocytes 
in vitro. For osteogenic differentiation, pericytes were cultured in medium containing ß-glycerol 
phosphate and dexamethasone. Alkaline phosphatase assay and von Kossa staining were used to 
characterize the progeny of pericytes grown in these conditions. Mean alkaline phosphatase 
activity of pericytes cultured in control and osteogenic medium after one week was 430.24 ± 
111.02 and 910.77 ± 406.15 U/mg total protein, respectively. We therefore observed an 
approximate 2.1-fold increase in the experimental group when compared to the control. After 
two weeks of culture, pericytes cultured in osteogenic medium maintained higher alkaline 
phosphatase activity than control cultured cells and mineralization was revealed by von Kossa 
staining (Figure 2-3 A, B). To induce chondrogenic differentiation, pericytes were cultured as 
pellets maintained in differentiation medium containing TGFβ-1. After three weeks, pellets 
exhibited cartilage-like round, smooth and shiny surfaces. Proteoglycans were synthesized by 
differentiated chondrocytes as shown by Alcian blue and safranin O staining of pellet sections 
(Figure 2-3 C, D, 20x). Lacuna eye structures were observed in the cell pellets, confirming the 
chondrogenic differentiation of pericytes (Figure 2-3 E, 40x magnification). Alcian blue and 
safranin O did not stain pellets cultured in control medium, and no lacuna eye structures were 
observed (data not shown). For adipogenic differentiation, pericytes were cultured in medium 
containing 1-methyl-3-isobutylxanthin, dexamethasone, insulin and indomethacin. Pericytes 
began to differentiate, as shown by the appearance of lipid vesicles in the cytoplasm, at week 3 
(data not shown). Pericytes cultured in adipogenic medium for 5 weeks contained accumulated 
lipid droplets. Oil red O brightly stained mature adipocytes (Figure 2-3 F).  
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Figure 2-3. Multilineage differentiation of cultured dental pulp pericytes. A, B - alkaline phosphatase and von 
Kossa stainings of pericytes cultured in control or osteogenic media. C, E – Alcian blue and D – Safranin O 
stainings of pellet section of cells cultured in chondrogenic media. F – Oil red O staining of cells cultured in 
adipogenic media. A-D: bar = 100 µm, E-F: bar = 50 µm. 
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2.5 DISCUSSION 
There is an enormous need to develop safe and effective methods to regenerate soft and hard 
tissues for craniofacial diseases such as head and neck cancers, trauma, birth defects, periodontal 
disease and pulp injuries. Cellular approaches provide an attractive option to develop therapies 
targeted for the craniofacial regeneration. Engineering cellular therapies for craniofacial 
regeneration requires the understanding of the cells and their regenerative potential. Current 
studies have focused on isolating dental pulp stem cells by utilizing different enrichment 
techniques, markers and various multi-lineage differentiation assessments. Many such studies 
used the total population of dental pulp cells and only few reported the characterization and 
tentative isolation of dental pulp stem cells using flow cytometry. Shi et al. were the first to 
characterize and compare different dental pulp candidate stem cell populations.[3] They have 
isolated clonogenic populations of DPSCs by their ability to adhere to plastic, similar to bone 
marrow stromal cells.[32] Colony-derived DPSCs formed mineralized nodules in vitro and 
generated dentin-pulp-like tissue in vivo.[29, 30] Using similar methods, Shi’s group also 
isolated stem cells from human exfoliated deciduous teeth (SHEDs) and showed that these cells 
are clonogenic and able to differentiate into neural cells, adipocytes and odontoblasts in vitro as 
well as osteogenic and odontogenic cells in vivo.[31] Alliot-Licht et al. have utilized total pulp 
cells and have shown that a population of α-SMA positive cells can form mineralized nodules in 
vitro, suggesting that the bone/dentin progenitors are perivascular cells.[33, 101] The reports 
mentioned above suggested that the dental pulp stem cells reside in the perivascular niche. Our 
group has recently demonstrated that one of the sources, if not the only one, of mesenchymal 
stem cells in multiple tissues is the pericyte.[98] We now extend this notion and hypothesize that 
pericytes are, or include, a stem cell population in the dental pulp.  
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We have focused on identifying and characterizing the dental pulp stem cells in the 
perivascular niche. Our data show that dental pulp perivascular cells express the pericyte markers 
CD146, SMA and NG2, but not the endothelial cell markers CD34 and vWF.  These data agree 
with previous studies by our group and others pertaining to the isolation of pericytes from other 
tissues.[3, 25, 95] We have shown that CD146+CD34-CD45-CD56- sorted dental pulp pericytes 
are highly clonogenic and multipotent, as was also demonstrated for pericytes derived from other 
human tissues.[94] Cultured pericytes express CD44, CD90 and CD166, which also applies to 
mesenchymal stem cell populations from various tissues.[32, 102-104] This further suggests that 
MSCs are derived from perivascular cells.   
With regard to the role of pericytes in mineralized tissues and their potential to 
differentiate into bone and dentin, we have shown that sorted dental pulp pericytes express 
Runx-2 and osteocalcin without the addition of ß-glycerolphosphate or dexamethasone. Our data 
agree with previous reports showing that perivascular cells behave like osteoblasts in vitro even 
without addition of ß-glycerolphosphate.[20, 21] In the presence of ß-glycerolphosphate or 
dexamethasone, dental pulp pericytes become mineralized in a similar manner as perivascular 
cells from other tissues such as the retina, brain, epididymal fat pad, skin, lung, placenta and 
aorta.[8, 10, 18, 19, 95] Furthermore, pericytes from bovine retinal microvessels at different 
stages of differentiation express alkaline phosphatase, Runx-2, osteopontin, osteonectin, 
osteocalcin and bone sialoprotein.[10, 15] The studies above demonstrated the osteogenic 
potential of pericytes in vitro.  In vivo, bovine retina pericytes and CD146+CD34-CD45-CD56- 
sorted pericytes also formed bone.[94] In addition, CD146+ dental pulp cells form ectopic dentin 
in immunocompromised mice.[3] Together, these results suggest the potential use of dental pulp 
pericytes for engineering mineralized tissues such as bone and dentin.  
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Our data clearly demonstrate that we have successfully isolated pericytes from human 
adult dental pulp as CD146+CD34-CD45-CD56- cells. This approach provides us with a well-
characterized stem cell population of high purity that can be expanded and differentiated. Dental 
pericytes should therefore be amenable to study and develop targeted dental therapies as well as 
bone regeneration strategies.  Specifically, dental cell therapies have recently garnered a lot of 
attention. Dentin, dental pulp, and cementum-periodontal complex regeneration has been shown 
with DPSCs, SHEDs and periodontal ligament stem cells.[105] Root-periodontal complex 
regeneration has been shown with cells from apical papilla and periodontal ligament.[106] Hard 
tissue formation with rat dental pulp cells has also been shown in vivo.[107] FACS isolated 
dental pulp pericytes provide a unique cell source to assess the in vivo differentiation potential of 
these cells into dental tissues. Due to the availability of milk teeth and extracted adult teeth, 
dental pulp pericytes can provide a convenient source of therapeutic cells to regenerate dental 
tissues as well as tissues of other mesodermal lineages such as bone, cartilage and fat.  
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3.0  PHOSPHOPHORYN SIGNALING MECHANISM IN HMSCS, INVOLVEMENT 
OF INTEGRINS AND CROSSTALK AMONG MAPK AND SMAD PATHWAYS 
3.1 SUMMARY 
Stem cell maintenance and differentiation are directed by ECM proteins. Integrins are the key 
cell surface receptors that mediate cell-ECM interaction. PP, an ECM protein, has been shown to 
signals osteogenic differentiation in hMSCs through the MAPK and Smad pathways. PP does not 
activate the Smad pathway by BMP-2/4 receptor and the mechanism governing Smad activation 
remains elusive. We hypothesized that 1) PP signals by binding to integrins and 2) there is 
crosstalk between MAPK and Smad in the PP signaling mechanism. To test our first hypothesis, 
we used antibodies against αvβ3 or α2β1 to block the integrins and then treated cells with PP and 
monitored the downstream signaling events. We showed the involvement of integrins αvβ3 and 
α2β1 in PP signaling. Western blot showed that downstream MAPK was decreased by blocking 
of the integrins αvβ3 or α2β1. To prove our second hypothesis, small interfering RNA (siRNA) 
of ERK and p38 were used to assess the effect of PP on MAPK and Smad1. We demonstrated 
p38 have promoting effects on both ERK and Smad1 activation while ERK has an inhibitory 
effect on Smad1 activation. We conclude that PP directs hMSC osteogenic differentiation 
through integrins αvβ3 and α2β1 to MAPK signaling pathways and there is signaling crosstalk 
between ERK and p38 and that MAPK modulates the Smad pathway during PP signaling. 
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3.2 INTRODUCTION 
The ECM proteins provide structural support for the cells as well as signal cellular activities. 
Phosphophoryn belongs to the SIBLING family of proteins found in dentin and bone, has been 
shown to signal cell differentiation towards the osteogenic lineage.[57] The expression levels of 
osteogenic genes, such as alkaline phosphatase, runx2/cbfa1, osteocalcin, osterix, and bone 
sialoprotein, were upregulated in mouse fibroblast (NIH3T3), mouse osteoblast (MC3T3), and 
human mesenchymal stem cells (hMSCs) when stimulated with PP. We have shown previously 
that PP signals through integrins, MAPK, and Smad pathways.[57, 58] PP was shown to play an 
important role in matrix mineralization.[108, 109] PP also has a signaling role in directing cell 
differentiation into the osteogenic lineage. We previously reported that PP induces upregulation 
of osteogenic genes Runx2/Cbfa-1 and osteocalcin as well as osteocalcin protein production 
through the MAPK and Smad1 pathways in hMSCs.  
MAPK pathways are involved in a broad range of cellular events from growth, 
differentiation, and development to inflammation and apotosis.[110] The extracellular stimulus 
transduce its signal through MAPK leading to biological responses. MAPK pathways are 
mediated through a cascade of phosphorylation events by kinases. MAPK has been shown to be 
activated through integrin binding to the ECM.[111] PP was shown to activate ERK, JNK, and 
p38 components of the MAPK pathway.[57]  
The Smad pathway is important in osteogenic differentiation and it is known to be 
activated by members of the TGF-β family such as BMPs. When Smad1 is activated, it 
complexes with Smad4 and is translocated into the cell nucleus to regulate targeted gene 
expression.[112] In our previous study, we have shown that Smad1 is activated by PP, although 
not through BMP-2/4 receptor.[58] The blocking of BMP-2/4 receptor by noggin did not inhibit 
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the Smad1 activity stimulated by PP. How PP signals Smad1 and triggers nuclear translocation 
remains an unanswered question. We hypothesize that the activation of Smad1 could be 
attributed to signaling crosstalk between MAPK and Smad.   
Integrins are the major receptors for cell adhesion to ECM proteins.[113] Integrins are a 
family of transmembrane proteins composed of α and β subunits with each αβ combination 
having its specific binding and signaling properties.[111] We observed the gene expression of 
Runx2 downregulated when integrin αvβ3 was blocked prior to PP treatment of the hMSC.[57] 
Therefore we deduced that PP signals through αvβ3. However, the runx2 expression after 
blocking of αvβ3 did not return to untreated control, suggesting that other receptors such as other 
types of integrins might be involved. Various integrins are found in hMSCs such as α1β1, α2β1, 
α4β1, α5β1, α6β1, α7β1, αvβ3, and αvβ5.[114, 115] We have selected integrins αvβ3 and α2β1 
to evaluate their involvement in PP signaling because they have been shown to be play a role in 
osteogenic differentiation and mineralization.[115-117] Integrin αvβ3 is the predominant 
receptor for vitronectin while α2β1 is the receptor for laminin and collagen.[114, 115]  
The specific aims of this study were to determine the involvement of integrins in PP 
signaling pathways and the mechanistic interactions between MAPK and Smad signaling 
pathways in hMSCs. To determine the involvement of integrins in PP signaling pathways, I 
looked specifically at the involvement of αvβ3 and α2β1 by blocking them with antibodies prior 
to treatment with PP. I examined the MAPK activated by PP after blocking of the integrins. I 
examined the crosstalk between MAPK and Smad by siRNA. The activity of ERK was knocked 
down by siRNA and its effect on Smad and p38 was evaluated. p38 was also knocked down by 
siRNA and its effect on ERK and Smad1 was examined. For the siRNA study, we have treated 
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cells with either full-length PP (F-PP) or recombinant PP (rPP), a truncated version of F-PP, to 
evaluate their signaling effect on hMSCs.  
3.3 MATERIALS AND METHODS 
3.3.1 Antibodies  
Primary antibodies used were mouse anti-human αvβ3 (Chemicon), mouse anti-human α2β1 
(Millipore), rabbit anti-human ERK (Cell Signaling Technology), rabbit anti-human phospho-
ERK (Cell Signaling Technology), rabbit anti-human JNK (Cell Signaling Technology), rabbit 
anti-human phospho-JNK (Cell Signaling Technology), rabbit anti-human p38 (Cell Signaling 
Technology), phospho-p38 (Cell Signaling Technology), rabbit anti-human phospho-smad1 (Cell 
Signaling Technology), rabbit anti-human smad1 (Cell Signaling Technology). Secondary 
antibody used was goat anti-rabbit IgG (H&L), HRP-linked (Cell Signaling Technology).  
3.3.2 Generation of rPP 
Recombinant PP (rPP) was generated as previously described.[57] Isolated mouse genomic PP 
was used as a template to amplify exon 5 by PCR. The primers used were designed with SalI and 
XbaI at the 5'-ends of the gene-specific sequence for rPP; PstI and XhoI for F-PP. rPP and full-
length rPP were generating using the following primers. The primers used for rPP were 
CTAATGTCGACATGGAGAGTGGCAGCCGTGGAGA-3' (forward) and 5'-
GCATTCTAGATTAAAGCACCCGCCATTCAAATCG 3' (reverse).  The primers used for full-
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length rPP were 5'-CTGGTTCTGCAGGGATCCCCGAATTCCG-3' (forward) and 5'- 
GCCGCTCGAGCTAATCATCACTGGTTGAGTGGTT3' (reverse).  
The thermocycling conditions were three cycles of 94 °C for 70 s (denaturation), 52 °C 
for 70 s (annealing), and 72 °C for 2 min (extension) followed by 30 cycles of 94 °C for 70 s 
(denaturation), 62 °C for 70 s (annealing), and 72 °C for 2 min (extension). The amplified PCR 
fragment was inserted into the pGEX-4T-3 vector and transformed into the bacterial BL21 host 
cells. Cells were cultured in Luria-Bertani medium with ampicillin for 4 h at 30 °C. Protein 
expression was induced by 1 mM isopropyl-1-thio- -D-galactopyranoside for 3 h. The bacterial 
lysate was cleared by centrifugation and applied directly to glutathione-Sepharose 4B. After 
washing with PBS, the glutathione S-transferase-bound protein was eluted with thrombin. 
Thrombin was removed from eluates with p-aminobenzamidine immobilized on a Sepharose 4 
Fast Flow matrix. rPP and F-PP was stored at –80 °C until use. 
3.3.3 Cell Culture 
hMSCs (Center for Gene Therapy, Tulane University) were cultured in Minimal Essential 
Medium Alpha (GIBCO) supplemented with 16.5% Fetal bovine serum (Atlanta Biologicals), 
1% penicillin/streptomycin (GIBCO), and 1% L-glutamine (GIBCO) medium at 37 °C, 5% CO2 
with humidity. hMSCs were cultured up to passage four before use for experminets.    
3.3.4 Blocking of Integrins 
hMSCs were plated in 6-well plates and cultured until 80% confluent. Cells were serum-starved 
overnight. Antibodies αvβ3 or α2β1 (20 µg/mL) were added to the cells for 90 min. rPP (250 
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ng/mL) was then added to the cells for 10, 20, or 30 min. Negative controls include cells that 
were not treated with either antibodies or PP as well as cells treated with the antibody only. Cells 
were washed twice with cold PBS then ice cold radio immunoprecipitation assay buffer (RIPA) 
buffer (250 µL/well) was added and incubated on a shaker at 4 °C for 20 min. RIPA buffer was 
consisted of 150 mM NaCl, 1% Igepal CA-630, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM 
Tris, pH 8.0, 1 tablet/50 mL protease inhibitor cocktail tablet (Roche). Cells lysates were 
collected by scraping of the wells. Cell lysates were sonicated and centrifuged at 13,000 rpm for 
15 min. Supernatants were collected and stored at -80 °C until further use. Three sets of 
experiments were performed for each antibody and each time point was done in triplicates.  
3.3.5 siRNA 
Cells were cultured in 6-well plates for 24 h prior to siRNA transfection. 50 nM of siRNA (p38 
and ERK, Santa Cruz) were transfected using Lipofectamine 2000 (Invitrogen) for 12 h. After 72 
h from siRNA transfection, the media was supplemented with 250 ng/mL of rPP or F-PP for 10, 
20, 30, and 60 min. Concentration of PP and treatment time points were based on previous 
studies.  
3.3.6 Western Blot Analysis 
Cell lysates were quantified by BCA protein assay kit (Pierce) and loaded equally (15 µg) on 
homemade 10% SDS gels and resolved by SDS-PAGE. Gels were run at 120 V for 2 h then 
transferred onto PVDF membranes at 60 V for 2 h. Membranes were blocked with 5% milk and 
probed with primary antibodies (1:1000 dilution) overnight at 4 °C with gentle rotation. 
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Membranes were washed with Tris-buffered saline with Tween20 (TBST) and incubated with 
secondary antibody (1:8000 dilution) for 1 h at room temperature. Membranes were washed and 
bands were detected by chemiluminescence of HRP using Western Lightning enhanced 
chemiluminescence substrate (Perkin Elmer) and exposure to X-OMAT film (Kodak). 
Quantification of band intensities was performed by Kodak 1D 3.6 Image Analysis Software. For 
statistical analysis, two tailed paired student t-test was performed.   
3.4 RESULTS 
3.4.1 PP Signals through Integrins αvβ3 and α2β1 
To examine whether PP signal through integrins, specific antibodies against αvβ3 or α2β1 
integrins were used to block ligand-receptor interactions. The hMSCs were then treated with PP 
and the downstream MAPK (p-ERK, p-JNK and p-p38) signals were detected by Western blot. 
Antibodies against total ERK, JNK, p38 were probed on the same membrane as loading control 
for western blot. p-ERK, p-JNK and p-p38 were activated after PP treatment for 10, 20, and 30 
min (Figure 3-1 and 3-2). Western blot results showed PP signals through both αvβ3 and α2β1. 
When αvβ3 or α2β1 were blocked prior to PP treatment, the downstream MAPK signals were 
downregulated. When αvβ3 was blocked, p-ERK, p-JNK, and p-p38 were downregulated at 10, 
20, and 30 min (Fig 3-1). Similarly, when α2β1 was blocked prior to PP treatment, p-ERK, p-
JNK, and p-p38 were downregulated (Figure 3-2). Band intensity of the western blots was 
quantified by Kodak 1D 3.6 software (Figures 3-3 - 3-8). Band intensities of p-ERK, p-JNK, and 
p-p38 were normalized by total ERK, JNK, and p38 then divided by the control group to obtain 
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percent control values. Although not all groups showed statistical significant differences 
(p<0.05), the trends are similar among different western blots performed for MAPK activation 
by PP with or with ought inhibition of integrins αvβ3 or α2β1.     
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Figure 3-1. Blocking of αvβ3 in hMSCs prior to treating the PP. 
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Figure 3-2. Blocking of α2β1 in hMSC prior to treating the PP. 
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Figure 3-3. Blocking of αvβ3 in hMSC prior to treating the PP. Normalized p-ERK. 
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Figure 3-4. Blocking of αvβ3 in hMSC prior to treating the PP (student t-test, *p<0.05). Normalized p-
JNK. 
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Figure 3-5. Blocking of αvβ3 in hMSC prior to treating the PP (student t-test, *p<0.05). Normalized p-p38. 
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Figure 3-6. Blocking of α2β1 in hMSC prior to treating the PP (student t-test, *p<0.05). Normalized p-ERK. 
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Figure 3-7. Blocking of α2β1 in hMSC prior to treating the PP. Normalized p-JNK. 
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Figure 3-8. Blocking of α2β1 in hMSC prior to treating the PP. Normalized p-p38. 
 
3.4.2 MAPK and Smad Crosstalk 
PP’s signal is channeled via both the MAPK and Smad pathways and the crosstalk among these 
two pathways defines the downstream effect of PP. We have performed siRNA experiments of 
the MAPK and assessing the effect on the Smad pathway. We knockdown ERK or p38 
components of MAPK using siRNA and examine the activation of Smad1 by PP. We also 
knocked down ERK and look at the effect on p38 activation by PP.  
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3.4.2.1 ERK Inhibits the Activation of Smad1 
hMSCs were treated with ERK siRNA and then treated with rPP or F-PP for 10, 30, or 60 min. 
rPP is the truncated version of F-PP and we will compare the signaling effect of both forms of 
PP. Figure 3-9 shows the effect of ERK knockdown on the activation of MAPK and Smad1 by 
rPP and F-PP. When cells were treated with ERK siRNA, we observed a decrease of phospho-
ERK, ERK, Smad1. However, we observed an increase in phospho-Smad1 when ERK is 
knocked down. Similar results were observed for rPP and F-PP for all time points tested.  
Results from siRNA experiments were in agreement with previous results obtained from 
chemical inhibition experiments. Activation of MAPKs influences the Smad pathway at the level 
of pSmad1 nuclear translocation. PP signals through the Smad pathway and when Smad1 is 
activated, it is complexed with Smad4 and translocated to the nucleus. To investigate the effect 
of ERK on Smad signaling, chemical inhibitors were used to block the activity of ERK then 
examine their effect on Smad1 translocation to the nucleus. When U0126 inhibited MEK-1 from 
phosphorylating ERK, activation of ERK was blocked by U0126, phospho-Smad1 is translocated 
to the nucleus after PP treatment.[118]  
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Figure 3-9. ERK and Smad1 activity after ERK knockdown by siRNA 
3.4.2.2 p38 Enhances the Activation of ERK and Smad1 
hMSCs were treated with p38 siRNA and then treated with rPP or F-PP for 10, 30, or 60 min. 
Figure 3.10 shows the effect of p38 knockdown on the activation of MAPK and Smad1 by rPP 
and F-PP. When cells were treated with p38 siRNA, we observed a decrease in p38, phospho-
ERK, Smad1, and pSmad1. However, we observed an increase in phospho-smad1 when ERK is 
knocked down. Similar results were observed for rPP and F-PP for all time points tested. 
siRNA results were in agreement with previous results obtained from chemical inhibition 
experiments. When SB203580 inhibited MAPKK3/6 from phosphorylating p38, Smad1 nuclear 
translocation by PP was reduced.[118]  
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Figure 3-10. ERK and Smad1 activity after p-38 knockdown by siRNA 
3.5 DISCUSSION 
ECM-cell interaction plays a crucial role in stem cell maintenance and differentiation. 
Identifying cell surface receptors for ECM proteins is important in understanding how cells 
interact with the environment and ECM protein induced differentiation. In this study we report 
PP signal through integrins αvβ3 and α2β1. Previous results showed by blocking αvβ3, the gene 
expression of runx2 and osteocalcin downregulated in hMSCs.[57] Here we showed that the 
MAPK is inhibited when integrins αvβ3 or α2β1 are blocked. This provided explanations for the 
downregulation of the runx2 and osteocalcin gene expressions.  
Crosstalk among signaling pathways can modulate signal transduction from ECM to the 
nucleus. It was unclear how Smad1 is activated during PP signaling and we have demonstrated 
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that MAPK modulates the Smad1 pathway. We show that there is signaling crosstalk between 
ERK and p38 in the MAPK pathways during PP signaling. By siRNA we showed that, 1) ERK 
inhibits activation and the translocation of Smad1 to the nucleus, 2) p38 enhances the activation 
Smad1, and 3) p38 enhances the activation of ERK. The siRNA and chemical inhibition data 
were both in agreement.  
Our result indicated that ERK has an inhibitory effect on Smad1 activation and nucleus 
translocation and it is supported by the literature. Activation of ERK has been shown to have an 
opposite effect on the activation of Smad1. Smad1 consists of two globular domains, MH1 and 
MH2 domains, with a linker region between these domains that can be phosphorylated by ERK. 
The phosphorylation on the linker region opposes the effect of phosphorylation on the C-
terminus of Smad1 by BMPs leading to inhibition of nuclear translocation of the Smad 
complex.[75] In addition, ERK activation by anti-BMP, FGF, IGF-II has been shown to block 
epidermal differentiation, ventralization of the mesoderm and neural induction by inhibition of 
Smad nuclear translocation.[74]  
The p38 component of the MAPK pathway influences pSmad1 nuclear translocation. Our 
immunocytochemistry data showed that activation of p38 is required for Smad signaling and 
nuclear translocation. It has been shown in osteoblasts that Smad1 phosphorylation and 
translocation to the nucleus is suppressed when p38 is inhibited.[76] We showed that p38 not 
only affects the activation of Smad1, it also has a positive effect on the activation of ERK. It has 
been demonstrated that p38 modulates ERK signaling.[119-121]  
ECM-cell interaction plays a key role in signaling cell differentiation. The processes 
involved in stem cell differentiation into the osteogenic lineage and mineralization are complex 
and remain an area of research interest. Future studies include finding additional receptors for PP 
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and further understanding the complex signaling events involved in hMSCs differentiation into 
osteoblasts. PP may signal through receptors other than the integrins and trigger signaling 
pathways other than the MAPK and Smad pathways. Together these signaling pathways are 
modulated through crosstalk and lead to transduction to the nucleus to elicit cellular response. 
Cellular activities are controlled by highly complex and dynamic signaling pathways. Studying 
how these diverse signaling pathways are integrated by defining the crosstalk among the 
signaling pathways is essential for understanding cell fate decisions and tissue development.  
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4.0  PROTEOMIC PROFILING OF PP AND BMP-2 DIRECTED STEM CELL 
DIFFERENTIATION 
4.1 SUMMARY 
ECM proteins can direct stem cell differentiation through a variety of complex signaling 
pathways. To better understand the signaling pathways involved in stem cell differentiation into 
the osteogenic and odontogenic lineages, we stimulated mouse embryonic fibroblasts 
(C3H10T1/2) with PP or BMP-2 respectively. Using a quantitative mass spectrometry approach, 
we identified and quantified relative protein abundance differences for 1625 and 1973 unique 
proteins from total cell lysates obtained from the PP and BMP-2 treated groups with ratios 
(treated versus control) quantified. Proteins that were determined to be significantly up- or 
downregulated were further scrutinized and proteins of interest were selected for validation. In 
addition to a global proteome analysis, the phosphoproteome was evaluated in order to identify 
phosphoproteins involved in PP and BMP-2 directed stem cell differentiation.  
4.2 INTRODUCTION 
Stem cells have the ability to self-renew and differentiate into at least one of a number of 
different lineages.[122] Indeed, different populations of stem cells such as embryonic or adult 
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stem cells have very different differentiation potentials. Understanding the protein complement 
of these stem cell populations is important in helping to better classify their origin and to 
enhance our understanding of the proteins that govern cell fate decisions.[123] Multiple complex 
signaling events are involved during stem cell proliferation and differentiation. Recent advances 
in the field of proteomics provide the opportunity to identify proteins on either a global or 
targeted scale to study the mechanisms involved during stem cell differentiation in a systemic 
method.[124]  
ECM proteins signal cell differentiation, typically through activation of signaling 
cascades by phosphorylation of participating signaling proteins. Phosphorylation of these 
signaling proteins transduces stimuli from outside of the cell into the nucleus to instruct 
transcription of specific genes involved in differentiation. An evaluation of the phosphoproteome 
will allow us to identify signaling pathways involved during stem cell differentiation. 
Our goal is to identify and quantify proteins and phosphoproteins involved in stem cell 
differentiation towards the osteogenic and odontogenic lineages. In our model, we used PP and 
BMP-2 to stimulate C3H10T1/2 cell differentiation. PP has been shown to express in the dentin 
extracellular matrix while BMP-2 has been shown to stimulate osteogenic differentiation.[125] 
PP is a non-collagenous ECM protein found primarily in the dentin. It has been shown to signal 
through integrin, MAPK, and Smad pathways and upregulate Runx-2/Cbfa-1, alkaline 
phophatase, OCN, and Osx genes expression in hMSCs, MC3T3 cells, and NIH3T3 cells.[57] 
BMP-2 belongs to the TGF-β super family and it is known to signal through the Smad 
pathway.[67] Smad1 is phosphorylated by BMP-2 receptors and then, in complex with Smad4, 
translocates to the nucleus and participates in gene transcription with other factors such as 
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runx2.[126] Understanding the signaling proteins and mechanisms involved in bone and dentin is 
important for future mineralized tissue regeneration applications.  
In this study, we utilized stable isotope labeling of amino acids in cell culture (SILAC) to 
identify and quantify the total proteins and phosphoproteins found during cell differentiation 
towards osteogenic and odontogenic differentiation by PP and BMP-2 respectively. Our 
preferred cells to perform this study would be hMSCs, but hMSCs are not suited for SILAC 
experiments since they require a high number of cell passages which might change their 
phenotype. We then selected the mouse embryonic fibroblasts (C3H10T1/2) which are 
multipotent cells that can differentiate into osteoblasts, chondrocytes, adiopocytes similarly to 
hMSCs.[127] The data obtained from the SILAC experiments was then validated with western 
blot and immunohistochemistry.  
4.3 MATERIALS AND METHODS 
4.3.1 SILAC and Cell Treatment 
C3H10T1/2 (ATCC) were cultured in SILAC DMEM medium (Pierce) containing 10% dialyzed 
FBS and either the heavy (13C6) or light (12C6) L-lysine and L-arginine for more than six cell 
doubling time to ensure complete labeling of the proteome with the heavy labeled amino acids. 
In total, approximately sixty million cells were obtained from the culture, half each from the 
light media and heavy media cultured cells. Cells were serum starved overnight after which 
fifteen million cells from the heavy media culture were treated with 250 ng/mL of PP for 15 min, 
while the other fifteen million cells from the heavy media culture were treated with 150 ng/mL 
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of BMP-2 for 15 min. The thirty million cells from the light media received only serum-free 
medium to be used as an untreated control. After the treatment, cells were washed with ice-cold 
PBS, harvested from the tissue culture plates by scraping (to avoid tryptic digestion of cell 
surface proteins), and pelleted by centrifugation. Excess PBS was removed and the pellets were 
stored at -80 °C.  
4.3.2 Cell Lysis 
Cell lysis buffer (10 mM Tris pH 7.4, 5 mM EDTA, 6 M urea, 5 mM TCEP, 10 μM NaF, 50 μM 
Na3VO4, 1 mM PMSF) were added to the cell pellets (0.8 mL/pellet). Sonication was performed 
at a setting of 1, three times of 15-20 strokes with cooling on ice in between each set of pulses.  
4.3.3 Desalting 
Cell lysates were desalted with Pierce D-salt columns (Pierce). Columns were pre-equilibrated 
with 20 mL of 100 mM amonium bicarbinate (AmB). Samples were lyophilized to ~300 μl and 
loaded on the columns followed by an initial wash of 700 μl of 100 mM AmB and then 
consecutive washes of 500 μl of 100 mM AmB and each fraction (for a total of six) was 
collected. Each fraction was assayed to determine protein content using the Coomassie Plus 
Protein Assay (Pierce; 300 μl assay buffer + 10 μl sample). Fractions containing protein 
(typically 3-5) were combined and the final protein concentration for each pool/sample was 
determined by BCA (Pierce).    
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4.3.4 Fractionation by 1D-PAGE and In-Gel Digestion 
Samples were mixed at a 1:1 ratio of total protein for each heavy:light comparison (PP/control 
and BMP/control). For one dimensional (1D)-sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (PAGE) fractionation, thirty μl of total cell lysates (heavy and light mixed at 1:1 
ratio) were resolved on a 4-12% Bis-Tris gradient gel (Invitrogen) in MES running buffer at 170 
V and the gel was stained with Coomassie (Simply Blue Safe Stain, Invitrogen). Gels lanes for 
each sample mixture were separated into ten bands, excised and cut into approximately 1 mm x 1 
mm pieces, and placed into individual eppendorf tubes. Gel pieces were destained in 1 mL of 50 
mM AmB/50% acetonitrile (ACN) with a fresh solution change after 30 min. Destain solutions 
were removed and 200 μL of 100% ACN was added to each tube for 5 min, the solution 
aspirated out and gel pieces were incubated at 37 °C to dehydrate the gel pieces. Samples were 
then incubated with 100 μL of porcine sequencing-grade modified trypsin (20 ng/μL, Promega) 
on ice for 40 min. Excess trypsin solution was removed and 100 μL of 25 mM AmB was added 
and samples were incubated at 37°C overnight. The digest solution was removed to a new tube 
and 75 μL of extraction buffer containing 70% ACN/5% FA was added and samples were 
sonicated for 10 min in a water bath, and the solution was combined with the overnight digest 
previously replaced to a new tube. The extraction procedure was repeated two more times and 
the samples were, lyophilized to dryness and stored at -80 oC. 
4.3.5 Phosphoenrichment with Titanium Dioxide (TiO2) 
Cell lysates from PP/control or BMP-2/control groups (mixed at 1:1 ratio for 1 mg of total 
protein) were boiled for 5 min and digested with trypsin (1:50 enzyme:protein ratio) overnight at 
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37 oC. Samples were lyophilized to dryness and resuspended in 1 mL of TiO2 enrichment loading 
buffer (80% ACN, 0.1% TFA, 30 g/L dihydroxybenzoic acid (DHB)). Each sample was divided 
equally into two eppendorf tubes and phosphoenrichment was performed using a slightly 
modified protocol described in the literature.[128] First, 20 mg of TiO2 beads were washed in 
400 μL 20% ACN, pH 10.5, then with 400 μL of 50% ACN/0.1% TFA, and finally with 420 μL 
80% ACN, 0.1% TFA, 30 g/L DHB. The washed beads slurry was split equally into four 
eppendorf tubes (~5 mg of TiO2 beads per tube) and incubated with 500 μL of the sample for 1 h 
with gentle rotation at 4 °C. Sample mixtures (with beads) were transferred to spin columns and 
were washed with 500 μL of 80% ACN, 0.1% TFA, 30 g/L DHB and then again with 500 μL of 
50% ACN/0.1% TFA at 100 x g for 1 min. Phosphopeptides were eluted with three consecutive 
washes with 100 μL 20% ACN (pH>10.5), and samples were neutralized immediately with 25 
μL of 10% TFA (placed in the collection tube). Samples were lyophilized to dryness, 
resuspended in 0.1% TFA and desalted with C18 ZipTip microcolumns (Millipore) according to 
the manufacturer’s instructions, lyophilized again and stored at -80 oC until analysis.      
4.3.6 Mass spectrometry and Data Analysis 
For the global analysis, each band from the in-gel digestion was resuspended in 0.1% TFA and 
analyzed in duplicate by nanoflow reverse phase liquid chromatography (RPLC)-MS/MS using a 
Dionex Ultimate 3000 LC system coupled online with a hybrid linear ion trap (LIT)-Orbitrap 
mass spectrometer. Following injection, samples were loaded onto a C-18 reversed-phase trap 
column for 3 minutes at a flow rate of 30 µL/min with mobile phase A (2% ACN, 0.1% FA). 
Peptides were eluted from the C-18 trap column onto an analytical column (75 μm i.d. x 360 μm 
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o.d. x 45 cm fused silica with a flame-pulled tip and packed in-house with Jupiter 5 µm C-18 
reversed phase stationary phase [Phenomenex] using a slurry packer) for increased peptide 
separation prior to electrospray ionization (1.6 kV) and analysis in the mass spectrometer. 
Peptides were eluted from the analytical column over the course of 130 minutes increasing 
mobile phase B (100% ACN, 0.1% FA) from 2% to 42% and then increasing mobile phase B to 
95% over the next 15 minutes. The column was washed at 95% mobile phase B for 20 minutes 
before re-equilibration at 100% mobile phase A prior to the next injection. The mass 
spectrometer was operated in a data-dependent mode where the first scan event was a broad mass 
range scan in the Orbitrap from m/z 375-1800 at a resolution of 60,000 followed by tandem MS 
(MS/MS) of the top seven most abundant ions in the LIT using collision induced dissociation at a 
normalized collision energy of 35. To avoid redundant identification of abundant ion species, 
molecular ions selected for MS/MS were dynamically excluded from being selected for tandem 
MS again for ninety seconds or until their signal-to-noise dropped below a certain threshold 
(early expiration). For the phosphoproteome analyses, TiO2-enriched samples were resuspended 
and analyzed similarly but with five replicate injections rather than in duplicate to increase the 
number of identifications due to lack of the gel fractionation step used in the global analyses.  
Raw data from the nanoflow RPLC-MS/MS analyses were searched against the mouse 
protein database (UniProt, 10-08 version, www.expasy.org) using Sequest (Bioworks Browser, 
ThermoFisher Scientific). Peptides were searched using the following parameters: tryptic criteria 
with up to two missed cleavages, 20 ppm mass tolerance for the molecular ion and dynamic 
modifications of 6.0201 for lysine, 10.0336 for arginine, and 15.9949 for methionine. SILAC 
ratios were determined from the areas obtained from reconstructed ion chromatograms of the 
heavy and light peptides for a given peptide pair using the PepQuan software in the Bioworks 
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Browser Software. For the phosphopeptide analyses, an additional dynamic modification of 
79.9663 on serine, threonine and tyrosine was allowed. Data were further filtered by stringent 
cross correlation versus charge state criteria as follows; [M+H]+, ≥ 1.9; [M+2H]2+, ≥ 2.2; 
[M+3H]3+, ≥ 3.5; and [M+4H]4+ and higher, ≥ 5.0; and a delta correlation of ≥ 0.08 for all cases. 
Tables of unique proteins (identified by peptide sequences that can be found in only one protein 
entry in the database) and common proteins (identified by peptide sequences that can be found in 
more than one protein entry in the database) were generated with average and standard deviation 
of heavy-to-light ratios (H:L), from which only those proteins with a percent standard deviation 
less than forty (SD/Avg*100) were considered for further scrutiny. Gaussian distributions of 
these highly filtered groups of proteins were generated and statistically significant over- and 
under-expressed proteins were determined for each. Proteins of interest were manually verified 
from the raw data prior to validation by IHC and western blotting. 
4.3.7 Ingenuity Pathway Analysis 
Ingenuity Pathways Analysis (IPA) 7.1 – 2002 was used to aid data analysis of the SILAC 
experiment. The IPA software is used for exploring functions of a gene or protein of interest, 
interpretation of protein interactions, network construction of a set of proteins, and data set 
comparisons. IPA’s search, analysis, and network construction functions are based on the 
Ingenuity knowledge base, which is compiled from published peer-reviewed literature and 
facilitates analyzing large sets of data in a systematic manner. Protein accessions and their 
corresponding average ratios were imported to IPA for core analysis. Analysis settings are as 
follows: Functions/Pathways/Tox List Analyses Reference Set - Ingenuity knowledge base 
(genes only), Network Analysis – direct and indirect relationships, includes endogenous 
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chemicals, and consider all species, tissues & cell lines, and data sources. From the core analysis, 
top networks with associated network functions of a particular dataset is constructed along with 
top biofunctions (diseases and disorders, molecular and cellular functions, physiological system 
development and function), top canonical pathways, top molecules (fold change up-regulated 
and down-regulated). For the global analyses, the PP/control and BMP/control data sets (unique 
and common) were imported into IPA for further analysis of the networks and functions of 
proteins identified.  
4.3.8 Western Blot Analyses 
Cells were treated identically as those for SILAC experiment without the supplementation of the 
labeled isoptopes. C3H10T1/2 cells were serum starved overnight and treated with PP or BMP-2 
(both at 250 ng/mL) for 15 min. After washing twice with ice-cold PBS, cells were incubated in 
lysis buffer (150mM NaCl, 1% Igepal CA-630, 0.5% sodium deoxycholate, 0.1% SDS, 50mM 
Tris, pH 8.0, 1 tablet/50mL protease inhibitor cocktail tablet (Roche)) for 20 min, harvested, 
sonicated, and pelleted by centrifugation at 13,000 rpm for 15 min. Supernatants were collected 
and protein concentrations were determined by BCA. Equivalent amounts of each sample (20 
μg) were resolved by 1D-PAGE on 10% SDS gels at 120 V for 2 h, then blotted onto PVDF 
membranes at 60 V for an additional 2 h. Membranes were blocked with 5% milk and probed 
with primary antibodies overnight at 4 °C with gentle rotation. Membranes were washed with 
tris-buffered saline with Tween20 (TBST) and incubated with secondary antibody for 1 h at 
ambient temperature and washed again prior to band detection by chemiluminescence of HRP 
using Western Lightning enhanced chemiluminescence substrate (Perkin Elmer) and exposure to 
X-OMAT film (Kodak). Primary antibodies used were rabbit anti-14-3-3 ε (1:1000 dilution, Cell 
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Signaling Technologies), rabbit anti-eIF2A-phosphoS51 (1:500 dilution, abCam) rabbit anti-
eIF2A (1:500 dilution, abCam), rabbit anti-Ras (1:1000 dilution, Cell Signaling Technology), 
rabbit anti-Coronin 1C (1:500 dilution, Santa Cruz Biotechnology), rabbit anti-androgen receptor 
(1:200 dilution, Santa Cruz Biotechnology). Secondary antibody used was anti-rabbit HRP 
(1:8000 dilution, Cell Signaling Technology).  
4.3.9 Immunohistochemistry 
Cells were treated identically as those for SILAC experiment without the supplementation of the 
labeled isoptopes. C3H10T1/2 cells were plated in 48-well tissue culture plates, serum starved 
overnight, and treated with PP or BMP-2 (both at 250 ng/mL) for 15 min. Cells were then 
washed twice with ice-cold PBS and fixed in 4% paraformadehyde for 15 min. Cells were 
washed with wash buffer (0.05% Tween-20 in PBS), permeabilized with 0.1% Triton X-100 in 
PBS for 5 min, and incubated with blocking buffer (5% donkey serum in PBS) for 1 h at ambient 
temperature. Cells were incubated in primary antibody overnight at 4 °C and washed three times 
in wash buffer prior to addition of secondary antibody and incubated for 1 h. Cells were washed 
twice with PBS and imaged with a Nikon fluorescent microscope. Primary antibodies used were 
AR (1:50 dilution, Santa Cruz Biochenology). The secondary antibody used was donkey anti-
rabbit Alexa 488 (1:500 dilution, Invitrogen).  
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4.4 RESULTS 
Cells were labeled with heavy or light lysine and arginine by culturing in media for at least 5 
passages to ensure complete incorporation of the heavy isotope amino acids into the proteome. A 
flow chart summarizing the SILAC-based experimental workflow is shown in Figure 4-1. 
Heavy-labeled cells were treated with PP or BMP (250 ng/mL) for 15 min while light-labeled 
cells were used as untreated control. Cells were lysed and mixed at a heavy to light ratio of 1:1 
based on total protein content. For global proteome analyses, total cell lysates were resolved by 
1D-PAGE and sample lanes were separated into ten fractions and bands were excised for in-gel 
trypsin digestion. For phosphoproteome analyses, cell lysates were digested in-solution with 
trypsin then enriched for phosphopeptides with an established protocol using TiO2 beads.   
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Figure 4-1. SILAC-based experimental workflow 
 
 
4.4.1 Heavy Lysine and Arginine Labeling in C3H10T1/2 Cells 
Prior to PP or BMP-2 treatment, cells cultured in heavy or light lysine and arginine medium were 
lysed, digested with trypsin (1:50 enzyme:protein ratio), and the resultant peptides were analyzed 
to ensure full incorporation of labeling. We observed that complete incorporation of heavy 
arginine and lysine amino acids into the proteome occurred after a minimum of five cell 
doubling times. Figure 4-2 illustrates an example of a pair of isotopomeric peptides from 
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aminopeptidase showing a mass difference of m/z 5 for the doubly charged peptide (10 amu) 
containing a heavy labeled arginine and an approximate ratio of 1:1 from the relative abundance 
of the molecular ions for the light and heavy peptides. 
 
Figure 4-2. Peptide isotope pair showing a difference of  m/z 5 amu for the heavy arginine-containing 
peptide with a relative abundance of 1:1 between control and treated. 
4.4.2 Protein Fractionation by 1D-PAGE 
Mixed cell lysates were resolved by 1D-PAGE, the gel stained by Simply Blue Safe Stain and 
ten bands were excised for in-gel digestion as shown in Figure 4-3. Following digestion with 
trypsin, samples were analyzed by nanoflow reversed-phase liquid chromatography-tandem mass 
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spectrometry. Insets in Figure 4-3 show representative base peak chromatograms from the 
RPLC-MS/MS analysis of peptides extracted from a few of the individual gel bands showing 
varying complexities within each band. The use of 1D-PAGE effectively provides an initial 
dimension of fraction (by gel filtration) prior to mass spectrometric analysis which improves 
overall protein identification and quantitation. 
 
Figure 4-3. Protein fractionation by 1D-PAGE 
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4.4.3 Global Protein Profiling of PP and BMP-2 Treated C3H10T1/2 Cells 
Results from the global proteomic analyses of the PP/control and BMP-2/control samples 
resulted in the identification of 2751 and 3294 proteins respectively with 1924 and 2177 
identified by at least two peptides. Of the total number of proteins identified, 1625 (PP/control) 
and 1973 (BMP-2/control) were identified by unique peptides; 1124 and 1274 of those by two or 
more peptides respectively. Protein abundance changes were calculated by PepQuan from 
extracted ion chromatograms generated from heavy and light peptide pairs and reported as H:L 
values. To generate a list of highly confident proteins with ratios, average and standard deviation 
determinations of ratios for each protein were first trimmed using cut-offs of H:L of 100:1 and 
0.01:1 at the high and low extremes, and then further filtered for average ratios calculated from 
at least two peptides with different ratio values (a standard deviation greater than zero). Finally, 
proteins with ≤ 40% standard deviation (SD), calculated by dividing the standard deviation by 
the average and then multiplying by 100, were used for further analysis bioinformatic analyses. 
Normal distributions of the final, filtered data sets (from unique peptides) were generated using 
binned protein counts vs. log2 of the ratio and are shown in Figures 4-4 and 4-5. A Gaussian 
(normal) distribution was observed for both treatment groups where the majority of the proteins 
had a ratio (treated over control) around one (Log2 Ratio = 0). This analysis allowed us to 
evaluate a subset of the proteins which were significantly up- or downregulated (in this case 1σ 
from the mean ratio for each sample) to determine those proteins which might merit further 
validation and analysis.  
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 Figure 4-4. Normal distribution of binned protein counts vs. Log2 Ratio for PP/control group 
 
Figure 4-5.   Normal distribution of binned  protein counts vs. Log2 Ratio for BMP-2/control group 
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In evaluating the data, it was prudent to examine those proteins whose identification was 
derived from one or more peptides that are not unique to a given sequence within the database 
and can be found in several protein sequences. For these proteins, while definite assignment of 
their presence (and therefore the corresponding ratio) to a single, unique protein cannot be made, 
some insight into the nature of the biology that is taking place may be gleaned from looking at 
the list of possible proteins such as different isoforms or families of proteins. In these cases, 
proteins of interest that were selected after the previously described filtering were further 
inspected manually for the ‘commonality’ of the identification and the quality of the tandem 
mass spectra for each peptide used to determine the protein identification.   
Proteins identified from PP/control and BMP-2/control groups (total lysates, unique and 
common peptides) were imported to IPA software groups to examine protein functions and 
relations. The number of proteins identified for a particular cellular function was divided by the 
total number of proteins identified and multiplied by 100 to calculate the percent coverage. The 
distribution of cellular functions of proteins identified for PP/control and BMP-2/control groups 
are shown in Figure 4-6 and 4-7.  
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Figure 4-6. Distribution of protein functions in PP/control group 
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Figure 4-7. Distribution of protein functions in BMP-2/control group 
 
 72 
4.4.4 Phosphoprotein Profiling of PP and BMP-2 Treated C3H1-T1/2 Cells 
To identify the changes in signaling transduction components during stem cell differentiation, we 
performed phosphopeptide enrichment using TiO2 on digested cell lysates from cells treated with 
PP or BMP-2. From these analyses, 226 and 171 phosphopeptides were identified in the 
PP/control and BMP-2/control groups, respectively. Of the phosphopeptides identified, 135 and 
114 were by unique peptides in the PP/control and BMP-2/control groups, respectively, with 25 
proteins observed as upregulated and 26 as downregulated (more than 1 SD away from the mean 
ratio). However, manual verification of the peptide tandem mass spectra suggested that the 
complexity of the multiple modifications present in most cases (heavy labels, phosphorylation, 
etc.) and the lack of complete peptide fragmentation due to predominant loss of the 
phosphorylation modification during collision indueced dissociation (CID), led to the majority of 
them being questionable identifications, and therefore were not selected for further validation. As 
an alternative approach for phosphopeptide identification, we re-searched the global proteome 
data using similar criteria to that used for the TiO2-enrichment data, but encountered the same 
concerns on the credibility of the peptide identifications. 
To gain insights to additional signaling pathways in PP and BMP-2 signaling, top 
networks of the identified phosphoproteins were constructed by IPA using data from the TiO2 
enriched samples. The top network for PP/control group (identified from unique peptides) 
suggests the involvement of MAPK (ERK, JNK, P38) in PP signaling which we have shown 
previously (Chapter 3). Proteins upregulated by PP are shown in red and downregulated in green 
with proteins not identified shown in white. Direct relationships are shown in solid lines and 
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indirect relationships in dotted lines. In addition, other molecules that are involved and related to 
MAPK such as YWHAH and MAP3K3 were identified and shown in the network.  
 
Figure 4-8. Top network of PP/control (TiO2 enriched, unique peptides) 
 
 
 
 74 
4.4.5 Protein Validation 
From the global protein analysis, proteins of interest with significant changes in ratios were 
selected for validation and were validated manually for robust ion matching (good coverage of 
the b- and y-type fragment ions) in the tandem mass spectra and also for accurate ratio 
calculations from the extracted ion chromatograms of the heavy and light peptide pairs. Of the 
nearly 3,500 proteins identified in the two global data sets, five were finally selected for further 
validation (Table 4-9) by western blot and/or immunohistochemistry; coronin-1C (PP Unique), 
androgen receptor and eukaryotic initiation factor 2A (Eif2A) (BMP Unique), 14-3-3 ε (BMP 
Common), and Ras-related Rab32 (PP/BMP-2 Common). Complete tables of proteins 
upregulated or downregulated more than one SD away from the mean ratio are shown in 
Appendix A with Tables 5-1 - 5-4 showing proteins identified by unique peptides and Tables 5-5 
– 5-8 showing proteins identified with common peptides. 
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Table 4-1. Proteins selected for validation experiments  
UniProt Accession 
PP/control 
Fold Change 
BMP-2/control 
Fold Change 
Protein Name (Gene 
Name) 
Peptides 
Identified 
P19091 N/A 0.02 Androgen receptor (AR) 2 (unique) 
Q9WUM4 33.52 N/A Coronin-1C (Coro1C) 2 (unique) 
Q8BJW6-1 
Q8BJW6-2 
4.39 N/A 
Isoform 1 of Eukaryotic 
translation initiation factor 
2A (Eif2A) 
Isoform 2 of Eif2A 
2 (common) 
P62259 
 
A2ACM8 
N/A 8.51 
14-3-3 protein epsilon 
(Ywhae) 
Tyrosine 3- mono-
oxygenase /tryptophan-5-
mono-oxygenase activation 
protein,  epsilon 
2 (common) 
Q9CZE3 
Q8QZZ8 
Q91YQ1 
1.95 3.02 
Ras-related protein Rab-32 
Rab-38 
Rab-7L1 
2 (common) 
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For Western blot validation, total cell lysates from cells treated in a similar manner as the 
SILAC experiment were resolved by 1D-PAGE. Antibodies against proteins of interested were 
used to evaluate changes in protein abundances (Figure 4-9). Coronin 1C, phospho-Eif2A, and 
Eif2A increased in both BMP-2 and PP treated groups. Ras increased after PP treatment and no 
change was observed in the BMP-2 treated group. 14-3-3 ε increased after BMP-2 treatment and 
no change was observed for the PP treated group. Androgen receptor decreased in both BMP-2 
and PP treated groups. β-actin showed equal loading of the protein.  
 
Figure 4-9. Western blot validation of proteins identified from mass spectrometry 
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In addition to western blot, immunocytochemistry was performed on C3H10T1/2 cells 
treated with PP or BMP-2 (250 μg/mL) for 15 min. Androgen receptors were expressed in the 
cytoplasm as well as the nucleus. No significant change in androgen receptor expression 
intensity or location for cells treated with PP or BMP-2 when compared to control (Figure 4-10).  
 
Figure 4-10. Androgen receptors staining in cells treated with BMP-2, PP, or untreated control 
4.5 DISCUSSION 
To study the early differentiation mechanism stem cells into the bone or dentin lineages. 
C3H10T1/2 cells were stimulated with PP to induce odontogenic differentiation or with BMP-2 
to stimulate osteogenic differentiation. SILAC was utilized to identify and quantify proteins 
involved during stem cell differentiation. Proteins found with significant change in ratio were 
evaluated and five proteins were selected for further validation. We have selected Coronin-1C, 
14-3-3 ε, androgen receptor, Ras, and eukaryotic initiation factor 2A (Eif2A) to perform western 
blot analysis.  
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Coronin-1C is an actin binding protein that is involved in actin cytoskeletal remolding, 
cell motility, and vesicle trafficking.[129] From the SILAC experiment, coronin-1C was 
identified and had a 33.5 fold increase in the PP treated group. From western blot analysis, we 
observed an increase in cells treated with either PP or BMP-2. PP has been shown to signal 
through the integrins (Chapter 3). Integrins are transmembrane proteins that interact with the 
extracellular matrix and are closely associated with actin cytoskeleton. Clustering of focal 
adhesion points occurs upon activation of integrins as well as signal transduction.[130] In 
addition, BMP-2 has been shown to induce actin cytoskeleton reorganization through Cdc42 
small GTPase and the alpha-isoform of the phosphoinositide 3-kinase (PI3Kalpha).[131] 
Coronin 1C could play a role in cytoskeletal remodeling stimulated by PP or BMP-2. 
14-3-3 ε, also known as tyrosine 3-monooxygenase/tryptophan 5-monooxygenase 
activation protein, epsilon polypeptide, (YWHAE) belongs to the 14-3-3 family of phospho-
serine/phospho-threonine binding proteins that mediate signal transductions including MAPK 
and AKT signaling pathways.[132] 14-3-3 has also been shown to regulate RGK-mediated 
cytoskeleton reorganization.[133] I observed an increase in 14-3-3 ε in cells treated with BMP-2 
from both mass spectrometry and western blot data. PP has been shown to activate the 
MAPK.[57] 14.3.3 is involved in initiation of Raf kinase activation that leads to the Ras-Raf-
MAPK pathway. Although 14-3-3 ε was not upregulated in cells treated with PP, other members 
of the 14-3-3 family could be involved in PP signaling.    
Ras is a family of guanine-nucleotide binding proteins that could be stimulated by 
receptor tyrosine kinases and G-protein coupled receptors, which then activate the Raf-MEK-
MAPK pathway. Ras-related Rab, identified from the mass spectrometry data, and was increased 
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in cells treated with PP or BMP-2.[134] The peptides identified were common peptides that 
could belong to Rab32, Rab38, or Rab7L1. Antibodies against mouse Rab32, Rab38, or Rab7L1 
were not commercially available. Therefore, a Ras antibody that binds to K-Ras, N-Ras, and R-
Ras was selected for western blot analysis. We observed an increase of Ras in PP treated group. 
PP has been shown to activate the MAPK and Smad pathways.[58] Smad is activated by PP 
independent of the BMP-2 receptor. I have shown that Smad1 could be regulated by crosstalk 
between ERK and P38 (Chapter 3). Ras is upstream of ERK and it has been previously shown to 
regulate Smad activation.[135] This provides an additional rationale to how PP activates the 
Smad signaling.  
Androgens and androgen receptors are important for bone metabolism.[136] Androgen 
receptor is a nuclear receptor that is expressed in the cytoplasm and when activated it is 
translocated into the nucleus and act as a transcriptional factor.[137] Androgen receptor was 
identified and showed a decrease in BMP-2 treated cells by mass spectrometry and western blot. 
Studies have shown that androgen receptor is inactivated by phospho-Smad1 that is activated by 
BMP-2.[138] Immunocytochemistry showed the expression of androgen receptor in the 
cytoplasm and the nucleus, however the assay was not sensitive enough to differentiate cells 
treated with PP or BMP-2 with untreated control.   
Eukaryotic initiation factor 2 alpha (Eif2A) is phosphorylated by eukaryotic translation 
initiation factor 2 alpha kinase 3 (Perk). Perk is essential for neonatal skeletal development.[139] 
Perk knockout mice showed skeletal defects such as deficient mineralization, osteoporosis, and 
abnormal compact bone development.[140] We showed an increase of Eif2A in the BMP-2 
treated cells by mass spectrometry. Western blot analysis showed an increase on phospho-Eif2A 
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as well as Eif2A for both PP and BMP-2 treated cells. Eif2A could play a role in bone 
development and mineralization as well as dentin development.    
 Through a quantitative proteomics approach, we have identified several proteins that 
could be involved in stem cell differentiation into the dentin and bone lineages. Future 
experiments include improvement of phosphopeptide enrichment and further validation of the 
proteins identified such as western blot, immunohistochemistry, siRNA, and drug inhibition 
assays. Using quantitative proteomic techniques such as SILAC, mechanism of stem cell 
differentiation into different lineages can be studied in an efficient and systematic manner.   
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5.0  CONCLUSIONS AND FUTURE DIRECTIONS 
Mineralized tissue engineering requires appropriate cell source, growth factors, and scaffolds. In 
this study, different cell sources were investigated including dental pulp pericytes, hMSCs, and 
mouse embryonic fibroblasts (C3H10T1/2). Human dental pulp pericytes were characterized, 
isolated, and tested for their multilineage differentiation potential (Chapter 2). Interaction 
between stem cells and ECM-proteins were investigated to better understand the most suitable 
microenvironment for stem cell differentiation into mineralized tissues. Our goal was to study 
the signaling roles of ECMs found in bone and dentin and to assess their potential incorporation 
in a scaffold to create a compatible stem cell microenvironment. The effect of PP on hMSCs cell 
surface receptors and crosstalk among signaling pathways was assessed (Chapter 3). To further 
elucidate the mechanism involved in stem cell differentiation into the odontogenic and 
osteogenic lineages, mass spectrometry (Chapter 4) was utilized to quantify protein abundance 
differences in mouse embryonic fibroblasts C3H10T1/2 cells that were stimulated with PP or 
BMP-2. Understanding the cell-ECM interaction and the signaling mechanisms during stem cell 
differentiation is important in controlling cell fate decision and tissue morphogenesis. 
Appropriate cell sources and signals to stimulate differentiation are crucial to the bioengineering 
of mineralized tissues.  
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5.1 DENTAL PULP PERICYTES 
5.1.1 Differentiation Potential of the Dental Pulp Pericytes 
Pericytes from adult human dental pulp were successfully characterized. CD146+CD34-CD45-
CD56- could be used to sort pericytes and they can be expended in culture (Chapter 2). Cultured 
pericytes showed high clonogenic ability and was able to differentiate in to chondrogenic, 
osteogenic, and adipogenic differentiation. Cultured pericytes expressed runx2 and osteocalcin. 
We have not yet assessed the in-vivo osteogenic/odontogenic differentiation potential of the 
dental pulp pericytes.  
5.1.2 Different Cell Populations in the Dental Tissues 
Besides the pericytes, there are other stem cell populations that may exist in the dental pulp. 
Furthermore, other dental pulp cell populations, such as endothelial cells, could potentially 
produce growth factors that support the pericytes. It has been shown that Stro-1, an MSC marker, 
could be used to isolate stem cells from dental tissues such as dental pulp and periodontal 
ligaments.[3, 141-143] It will be interesting to compare the differential potential of the total 
population, Stro-1 sorted cells, and pericytes in-vitro and in-vivo. CD146+CD34-CD45-CD56- 
has been used to sort pericytes from the dental pulp and it was also used to characterize 
periodontal ligaments. FACS results of cells from the periodontal ligaments were similar to those 
from the dental pulp (Appendix B). Besides the dental pulp and periodontal ligament, stem cells 
have also been suggested to reside in the apical papilla of permanent immature teeth (SCAP). 
These cells are involved in root maturation of the tooth and could be used in conjunction with 
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other cell types for bioengineering of the tooth.[144, 145] These cells could then be used to study 
their differentiation into odontoblasts and ultimately tooth formation. As the isolation and 
characterization experiments were ongoing, we began to assess the signaling role of PP, a 
bone/dentin extracellular matrix protein. 
5.2 PP SIGNALING MECHANISM 
5.2.1 Receptors for PP 
The data presented here shows that PP signals through integrins αvβ3 and α2β1 (Chapter 3). The 
experiments conducted were done by blocking integrins αvβ3 or α2β1 individully then looking at 
the downstream MAPK signaling activation. When integrins αvβ3 or α2β1 were blocked prior to 
PP treatment, the MAPK activity was downregulated but the signal was not completely inhibited. 
It would be of interest to see the effect of PP signaling when both αvβ3 and α2β1 are inhibited. If 
the MAPK activation from PP were not completely inhibited by blocking both αvβ3 and α2β1, 
then it will suggest that other receptors might be involved in PP signaling. One method to find 
additional receptors for PP is by a pull-down assay, similar to immunoprecipitation, followed by 
mass spectrometry analysis. First, PP would be tagged with biotin, then either cells to be treated 
with tagged PP or a total cell/membrane lysate would be incubated with the tagged PP and then 
associated proteins would be isolated using streptavidin to pull down PP-receptor complexes. 
This mixture would then be resolved by 1D-PAGE for in-gel digestion of bands of interest 
followed by MS identification. Studies have shown success in identifying novel receptors using 
the affinity purification and mass spectrometry techniques.[146]  
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5.2.2 Effect of PP on Different Cell Types 
PP signals through the MAPK and Smad1 pathways in hMSCs, MC3T3, and NIH3T3 and 
upregulates bone/dentin related genes.[57] PP has been shown to upregulate Runx2 and OCN 
gene expression as well as alkaline phosphatase activity in human periodontal ligament cells 
(unpublished results). PP signaling in dental pulp pericytes and other stem cell populations are 
yet to be studied.  
5.2.3 PP Signaling Mechanisms 
We have shown that PP signals through integrin/MAPK and Smad1 pathways. ERK, JNK, and 
p38 were activated by PP and there are signaling crosstalk among MAPK and Smad1 (Chapter 
3). Activation of ERK inhibits Smad1 activation and nuclear translocation. Activation of p38 has 
a positive effect on ERK activation as well as Smad1 activation and nuclear translocation. The 
crosstalk among MAPK and Smad is complex and acts as intrinsic signaling control to regulate 
gene regulation. ERK activates c-FOS, while JNK activates ATF-2 and c-JUN. The AP-1 
transcription complex is composed of activated c-JUN protein which can homo- and/or 
heterodimerize with c-FOS.[147] For example, c-JUN/c-JUN or c-FOS/c-JUN can complex to 
form AP-1 transcriptional factor. AP-1 will then bind and activate osteoblast specific genes, 
enabling osteoblst differentiation.[148, 149] Future studies might include investigating whether 
c-FOS, c-JUN, AP-1, and ATF-2 are activated by PP.   
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5.3 GLOBAL PROTEOMICS APPROACHES 
5.3.1 SILAC 
We have used a SILAC-based mass spectrometry approach to evaluate changes in protein 
abundances when C3H10T1/2 cells were stimulated by PP or BMP-2 (Chapter 4). With the same 
approach, other cell types such as DPSCs and hMSCs could be used to study cell differentiation 
by various growth factors, keeping in mind that the cells need to be cultured for at least 5-6 cell 
doubling times in the SILAC medium before treatment to insure successful labeling of the heavy 
amino acids. In addition, improvements to the TiO2-based phosphoenrichment protocol are 
required (as described below) for a more complete evaluation of the signaling cascades activated 
in response to the treatment conditions. Therefore, an approach to immortalize these primary 
cells in the same fashion as the TERT-hMSCs could be incorporated.[150] 
5.3.2 iTRAQ 
Another quantitative proteomics approach, isobaric tag for relative and absolute quantitation 
(iTRAQ) could be used for the evaluation of multiple time points or dosing studies, of which up 
to eight different treatment groups can be compared. Unlike SILAC, which is a metabolic 
labeling process and occurs during cell culture, iTRAQ is a reagent-based chemical reaction 
which labels peptides at free amine groups, after proteins are isolated from cells. Up to eight 
experimental groups could be compared in a single iTRAQ experiment.[151, 152] For example, 
we can compare cells treated with PP or BMP-2 for 10, 20, 30, and 60 min in one set of 
experiments. While iTRAQ would be useful for comparing cells treated with multiple growth 
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factors, time points, and dosages, it requires additional steps during sample processing and as 
most chemical reactions, may suffer from inefficient labeling of the peptide substrates.  
5.3.3 Phosphoenrichment 
To study the signaling molecules involved in PP and BMP-2 stimulated differentiation, we 
utilized a TiO2 enrichment protocol to investigate the phosphopeptides from total cell lysates. 
However, the results were less than optimal and further modification of the protocol is required. 
Repeated incubation of the cell lysates with the TiO2 might improve the binding efficiency. Also, 
we have used a ‘batch’ or ‘bulk’ method (incubating cell lysates with a TiO2 bead slurry) in our 
phosphoenrichment protocol; a column-based method (passing cell lysates through column 
packed with TiO2 materials) might provide a more efficient enrichment. Besides using TiO2 
beads, we also briefly evaluated an IMAC-based approach utilizing Ga3+ (Sigma) in a 
preliminary study but the results were poor in our hands. An alternative method to enrich the 
phosphopeptides is to use antibodies that bind to phosphorylated peptides or proteins. It has been 
shown that 4G10 and PY100 can be used to enrich phospho-Tyrosine peptides.[82] We could use 
these antibodies to perform an immunoprecipitation, followed by 1D-PAGE and LC-MS to 
identify and quantify the phosphoproteins in stem cells treated with PP, BMP-2, or other ECM 
proteins and growth factors.  
5.3.4 Absolute Quantification 
We have achieved relative quantification of identified proteins by calculating ratios of proteins 
from PP or BMP-2 treated samples versus untreated controls by SILAC. In order to achieve 
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absolute quantification of a protein of interest, we could spike the samples with a known amount 
of peptide (from the protein of interest) and then calculate the amount of protein of interest by 
comparing its peptide peak intensity to that of the spiked peptide.  
5.4 SCAFFOLD FOR MINERALIZED TISSUE ENGINEERING 
Scaffolds can provide support for cells and can be incorporated with growth factors to be 
implanted in the site of injury of the host. In collaboration with Dr. Steve Little, we tested the 
mineralization potential of SAOS cells on a biomaterial, poly(ethylene oxide)-modified poly(β-
amino ester) (PbAE). Cells were seeded on surfaces coated with different percentage mixtures of 
poly(L-latic acid) (PLA) and PbAE or KK89 (a form of PbAE). Initial results indicated that cells 
seeded on 85% PLA + 15% KK89 enhanced mineralization (Appendix C). Different materials 
could elicit different cellular activities and also varying responses in different cell types. To 
further study the interaction of cell-scaffolds, cell viability and proliferation, differentiation, 
mineralization, and functional assays needs to be taken into consideration. Time-lapse video 
microscopy could be used to study cell migration, proliferation, and differentiation on surfaces 
coated with different materials. In addition, we could utilize proteomics to investigate proteins 
involved in cells’ responses to different materials. For bone tissue engineering, in-vivo studies 
such as ectopic bone formation and critical size bone defect studies could be conducted. Growth 
factor and gene delivery systems can also be incorporated into scaffold design to promote 
regeneration.  
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APPENDIX A 
SILAC SUPPLEMENTAL DATA 
Table 5-1. Proteins with unique peptides upregulated by PP treatment 
UniProt 
Accession 
Average 
Ratio 
Protein Name Peptides  
Q9CR51 79.32 V-type proton ATPase subunit G1 (Atp6v1g1) 2 
Q9D411-2 62.35 Isoform 2 of Testis-specific serine/threonine-protein kinase 4 (Tssk4) 2 
Q8CI04 48.16 Conserved oligomeric Golgi complex subunit 3 (Cog3) 2 
Q9WUM4 33.52 Coronin-1C (Coro1c) 2 
P05201 11.56 Aspartate aminotransferase, cytoplasmic (Got1) 2 
Q8VBT0 6.06 Thioredoxin domain-containing protein 1 (Txndc1) 2 
Q9D1A2 4.53 Cytosolic non-specific dipeptidase (Cndp2) 2 
Q9R190 2.40 Metastasis-associated protein MTA2 (mta2) 2 
Q91X76 2.20 5’-nucleotidase domain containing 2 (Nt5dc2) 5 
O70252 1.97 Heme oxygenase 2 (Hmox2) 3 
P70280 1.78 Vesicle-associated membrane protein 7 2 
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Table 5-2. Proteins with unique peptides downregulated by PP treatment 
UniProt 
Accession 
Average 
Ratio Protein Name Peptides  
Q80YQ1 0.14 Thrombospondin 1 (Thbs1) 3 
Q8C2Q3-1 0.14 Isoform 1 of RNA-binding protein 14 (Rbm14) 2 
Q6ZWV3 0.13 60S ribosomal protein L10 (Rpl10) 3 
Q9QZF2 0.13 Glypican-1 (Gpc1) 2 
P35486 0.08 Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial (Pdha1) 2 
Q5M9L1 0.02 60S ribosomal protein L36 (Rpl36) 2 
Q6IFT3 0.01 Keratin Kb40 (Krt78) 2 
Q9CZX7 0.53 Transmembrane protein 55A (Tmem55a) 2 
Q9JJK2 0.50 LanC-like proteins 2 (Lancl2) 2 
Q69ZX9 0.50 MKIAA0838 protein (Fragment) (Gls) 27 
Q9DBL7 0.38 Bifunctional coenzyme A synthase (Coasy) 2 
 
Table 5-3. Proteins with unique peptides upregulated by BMP-2 treatment 
UniProt 
Accession 
Average 
Ratio Protein Name Peptides 
P62305 63.12 Small nuclear ribonucleoprotein E (Snrpe) 2 
Q8CIR4 59.83 Transient receptor potential cation channel subfamily M member 6 (Trpm6) 2 
Q5M6W3 51.16 Uncharacterized protein C2orf63 homolog 2 
O70146 29.30 Dual specificity testis-specific protein kinase 1 (Tesk1) 2 
Q3UW12-2 24.35 Isoform 2 of cyclic nucleotide-gated cation channel alpha-4 (Cnga4) 2 
Q9CYL5 12.52 Golgi-associated plant pathogenesis-related protein 1 (Glipr2) 2 
Q9Z0N1 3.32 Eukaryotic translation initiation factor 2 submunit 3 (Eif2s3x) 3 
Q99LI7 3.11 Cleavage stimulation factor 77 kDa subunit (Cstf3) 2 
Q8C7K6 2.63 Prenylcysteine oxidase-like (Pcyox1l) 2 
P55012 2.32 Solute carrier family 12 member 2 (Slc 12a2) 5 
Q01721 2.31 Growth arrest-specific protein 1 (Gas1) 3 
Q60967 2.00 Bifunctional 3’-phosphoadenosine 5’-phosphosulfate synthetase 1 (Papss1) 2 
Q3UDW8 2.00 Heparan-alpha-glucosaminide N-acetyltransferase (Hgsnat) 2 
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Table 5-4. Proteins with unique peptides downregulated by BMP-2 treatment 
UniProt 
Accession 
Average 
Ratio Protein Name Peptides  
Q9QZE7 0.08 Translin-associated protein X (Tsnax) 4 
Q8C264 0.07 NOD-derived CD11c +ve dendritic cells cDNA (Bak1) 2 
P62307 0.07 Small nuclear ribonucleoprotein F (Snrpf) 6 
P61967 0.06 AP-1 complex subunit sigma-21A (Ap1s1) 2 
O35129 0.05 Prohibitin-2 (Phb2) 2 
Q8BFY6 0.04 Peflin (Pef1) 2 
Q9Z2Z6 0.03 Mitochondrial carnitine/acylcarnitine carrier protein (Slc25a20) 2 
P61226 0.03 Ras-related protein Rap-2b (Rap2b) 3 
Q8VED5 0.03 Keratin, type II cytoskeletal 79 (Krt79) 7 
P19091 0.02 Androgen receptor (Ar) 2 
Q9CPQ1 0.02 Cytochrome c oxidase popypeptide (Cox6c) 2 
Q8C0C7 0.40 Phenylalanyl-tRNA synthetase alpha chain (Farsa) 3 
Q921HB 0.38 3-ketoacyl-CoA thialase A, peroxisomal (Acaa1a) 2 
Q9DBZ1-2 0.38 Isoform 2 of Inhibitor of nuclear factor kappa-B kinase-interacting protein (Ikip) 2 
Q9D5L2 0.37 Adult male testis cDNA (4940426D05Rik) 2 
Q9CQ60 0.28 6-phosphogluconolactonase 2 
Q9D5V6 0.25 Synapse-associated protein 1 (Syap1) 2 
Q9DBZ1-1 0.22 Isoform 1 of Inhibitor of nuclear factor kappa-B kinase-interactin protein (Ikip) 2 
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 Table 5-5. Proteins with common peptides upregulated by PP treatment 
UniProt 
Accession 
Average 
Ratio 
Protein Name Peptides  
Q9WVB2 41.67 Transducin-like enhancer protein 2 (Tle2) 2 
P63013-1 38.73 
Isoform PMX1-B of Paired mesoderm homeobox 
protein 1(Prrx1) 2 
Q9CWU6-
1 35.29 
Isoform 1 of Ubiquinol-cytochrome c reductase 
complex chaperone CBP3 homolog (Uqcc) 2 
Q64010-1 28.73 Isoform Crk-II of Proto-oncogene C-crk (Crk) 2 
P63085 15.04 Mitogen-activated protein kinase 1 (Mapk1) 2 
Q9CZW2-1 13.92 Isoform 1 of Centromere protein N (Cenpn) 2 
P50247 9.58 Adenosylhomocysteinase (Ahcy) 2 
B1ATZ0 4.55 HGF-regulated tyrosine kinase substrate (Hgs) 3 
Q8BJW6-1 4.39 
Isoform 1 of Eukaryotic translation initiation factor 
2A (Eif2a) 2 
Q8C0I1 4.27 
Alkyldihydroxyacetonephosphate synthase, 
peroxisomal (Agps) 4 
Q69ZB2 2.29 MKIAA1758 protein (Fragment) (Cttnbp2) 2 
Q3TIV5-1 2.130 
Isoform 1 of Zinc finger CCCH domain-containing 
protein 15 (Zc3h15) 2 
Q9CZE3 1.950 Ras-related protein Rab-32 (Rab32) 2 
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 Table 5-6. Proteins with common peptides downregulated by PP treatment 
UniProt 
Accession 
Average 
Ratio 
Protein Name Peptides  
Q61703 0.01 Inter-alpha-trypsin inhibitor heavy chain H2 (Itih2) 2 
Q9CZH7 0.03 Matrix-remodeling-associated protein 7 (Mxra7) 2 
Q3TTY5 0.03 Keratin, type II cytoskeletal 2 epidermal (Krt2) 2 
P39061-3 0.27 
Isoform 1 of Collagen alpha-1(XVIII) chain 
(Col18a1) 2 
Q8BFS6-1 0.34 
Isoform 1 of Uncharacterized 
metallophosphoesterase CSTP1 (Cstp1) 3 
Q64331 0.35 Myosin-VI (Myo6) 3 
Q99LX0 0.48 Protein DJ-1 (Park7) 4 
O09159 0.51 Lysosomal alpha-mannosidase (Man2b1) 2 
Q60961-1 0.55 
Isoform Long of Lysosomal-associated 
transmembrane protein 4A (Laptm4a) 4 
P70302 0.56 Stromal interaction molecule 1 (Stim1) 6 
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Table 5-7. Proteins with common peptides upregulated by BMP-2 treatment 
UniProt 
Accession 
Average 
Ratio 
Protein Name Peptides  
A2AQ25-1 69.32 Isoform 1 of Sickle tail protein (Skt) 2 
Q9D1L0 31.86 
Coiled-coil-helix-coiled-coil-helix domain-
containing protein 2, mitochondrial (Chchd2) 2 
Q9QYP6-1 29.89 Isoform 1 of 5-azacytidine-induced protein 2 (Azi2) 4 
O35855 16.24 
Branched-chain-amino-acid aminotransferase, 
mitochondrial (Bcat2) 2 
Q5XG71 14.94 
Small subunit processome component 20 homolog 
(Utp20) 3 
B1ATZ0 14.88 HGF-regulated tyrosine kinase substrate (Hgs) 2 
Q9Z351-12 13.10 
Isoform 12 of Potassium voltage-gated channel 
subfamily KQT member 2 (Kcnq2) 2 
P62259 8.51 14-3-3 protein epsilon (Ywhae) 5 
Q9CX30-1 5.74 Isoform 1 of Protein YIF1B (Yif1b) 2 
Q9CZE3 3.02 Ras-related protein Rab-32 (Rab32) 2 
B2RWW6 2.33 
GCN1 general control of amino-acid synthesis 1-
like 1 (Yeast) (Gcn1l1) 2 
A2ARJ0 1.92 
Signal transducing adaptor molecule (SH3 domain 
and ITAM motif) 1 (Fragment) (Stam) 4 
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Table 5-8. Proteins with common peptides downregulated by BMP-2 treatment 
UniProt 
Accession 
Average 
Ratio 
Protein Name  Peptides  
O09106 0.01 Histone deacetylase 1 (Hdac1) 3 
P01029 0.02 Complement C4-B (C4b) 3 
O35969-1 0.02 
Isoform 1 of Guanidinoacetate N-
methyltransferase (Gamt) 2 
Q9JKF7 0.16 
39S ribosomal protein L39, mitochondrial 
(Mrpl39) 2 
Q64331 0.16 Myosin-VI OS=Mus musculus GN=Myo6 4 
P08730-1 0.20 
Isoform 1 of Keratin, type I cytoskeletal 13 
(Krt13) 2 
Q9DCG9 0.21 TRM112-like protein 2 
Q61584-1 0.23 
Isoform E of Fragile X mental retardation 
syndrome-related protein 1 (Fxr1) 2 
Q3U8W9 0.25 
Bone marrow macrophage cDNA, RIKEN full-
length enriched library, clone:I830045N07 
product:heterogeneous nuclear 
ribonucleoprotein R, full insert sequence 
(Hnrnpr) 4 
O09131 0.33 
Glutathione transferase omega-1 OS=Mus 
musculus GN=Gsto1 4 
Q3U882 0.37 
Bone marrow macrophage cDNA, RIKEN full-
length enriched library, clone:I830063I15 
product:Similar to SEC24 related gene family, 
member B (S. cerevisiae) homolog (Fragment) 
(Sec24b) 2 
Q91ZR2 0.39 Sorting nexin-18 (Snx18) 2 
Q9QXG4 0.41 
Acetyl-coenzyme A synthetase, cytoplasmic 
(Acss2) 2 
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APPENDIX B 
FACS ANALYSIS OF PERIODONTAL LIGAMENT CELLS 
Total populations of periodontal ligament cells were isolated from four human adult third 
molars (21 year old male). Periodontal ligament were digested in collagenase for 1.5 h at 37 °C 
and pass through cell strainers to obtain single cells suspension. Cells were stained with 
antibodies CD146, CD34, CD56, and CD56. IgGs were used as negative controls. FACS analysis 
of periodontal ligament cells are shown in Figure 5-1. CD56+ and CD45+ cells are gated out and 
CD146+CD34- cells can be isolated as shown in P6. P6 = 0.6%.  
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Figure 5-1.  FACS analysis of periodontal ligament cells. 
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APPENDIX C 
MINERALIZATION OF SAOS CELLS SEEDED ON PBAE (KK89) 
SAOS-2 cells were seeded (25,000 cells/cm2) on glass slides coated with different 
percent of KK89 with PLA and placed in 6 well plates. Culture cells in medium Alpha MEM + 
10% FBS + 1% Penicillin/Streptomycin + 2 mM L-glutamine without supplements. After cells 
are attached and appeared normal in cell growth morphology, supplements 50 µg/mL L-ascorbic 
acid, 5mM β-glycerophosphate, and 100nM dexamethasone were added on day three. Media 
were changed every 3-4 days and cells were stained for alkakine phosphatase (pink) and von 
Kossa (black) on Day 14.  
Table 5-9. Experiment groups with cells grew on different coated surfaces 
Groups Coated surfaces 
1 Tissue culture polystyrene 
2 100% PLA (Mw 40-45K, H) 
3 90% PLA + 10% KK89 
4 85% PLA + 15% KK89 
5 80% PLA + 20% KK89 
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Figure 5-2. Alkaline phosphatase and von Kossa staining of SAOS-2 cells seeded on tissue culture plastic, 
PLA, and different % of KK89 at week two. 
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